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Quinone methides (QM) can be delivered to alklyate specific sites with a 
single strand DNA through target promoted alkylation. Previous experimental results 
indicated that alkylation by DNA-QM self-adduct was too slow for application in a 
biological system. A new quinone methide precursor (QMP) with enhanced reactivity 
is necessary to accelerate the reaction.   
Previous study showed that an electron donating group present in the QMP 
would facilitate the generation of QM from the precursor and its regeneration from 
the reversible alkylation adducts. Therefore, new QMPs with increased electron 
density were designed. An electron rich QMP2 was successfully synthesized through 
a  benzylaldehyde derivative. As predicted, DNA-QM self-adduct formation was 
much faster using QMP2 than using the conventional precursor QMP1 without an 
electron donating group. Only 20 min was needed for QM2 to complete the 




conversion. The DNA-QM2 self-adduct also exhibited faster reaction for alkylation 
of the target single strand. A two-day incubation was necessary to achieve its 
maximal yield of 20% compared to 6 days required to achieve the maximal yield of 
16% for DNA-QM1. 
In order to target duplex DNA, QMP was coupled to triplex forming 
oligonucleotides (TFO) to deliver the QM to the major groove of DNA through triple 
helix formation. Alkylation products were observed with the DNA-QMP1 conjugate 
but not the DNA-QM1 self-adducts. An adjacent guanine in the sequence can 
increase alkylation yield from around 10% to up to 20%. QMP2 was also coupled to 
the TFO to generate the self-adduct DNA-QM2. Maximal duplex alkylation yield 
(15%) using DNA-QM2 self-adduct was achieved in 3 days if the triplex samples 
were incubated at room temperature. The alkylation yield increased to 20% with the 
DNA-QM2 self-adductwhen samples were incubated at 37 oC. The DNA-QMP2 
conjugate could even be activated at 37 oC without fluoride and resulted in an 
alkylation yield of up to 25%. The enhanced reactivity of the electron rich QMP2 
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Chapter 1:  Introduction 
1.1 Structure of DNA and DNA alkylation type 
Double strand DNA structure was first identified in 1953. It contains two 
polynucleotide strands wound about the same axis as a right handed helix.1  
According to this Watson and Crick model, there are four types of nucleotides bases 
attached to the DNA backbone: adenine (A), guanine (G), cytosine (C) and thymine 
(T) (Figure 1.1a), which can form hydrogen bonding to anneal the two strands.2  The 
backbone of the strand is the sugar-phosphate chains occupying the peripheral part to 
minimize the electrostatic repulsions between the two strands. In most cases, adenine 
forms a base pair with thymine through two hydrogen bonds and cytosine forms a 
base pair with guanine through three hydrogen bonds (Figure 1.1b). The hydrogen 
bond provides fixed conformations of the base pairs in DNA helical structure that 
result in very important differences of DNA major groove and minor groove (Figure 
1.2). The DNA major groove is much wider than the minor groove and it also 
contains more functional groups and less hydrophobic than minor groove.  These 
properties make the major groove an ideal place to interact with some small 















































(a)         
Figure 1.1 (a) Structure and numbering of bases in DNA; (b) base pairings of DNA. 
 
Figure 1.2 Structure of double helical DNA and the position of major and minor 





DNA is considered a very important target for biological study, because the 
double helical structure of DNA holds rich biological information of a living system. 
Its nucleotide sequence does not only code for protein and enzyme synthesis through 
transcription and translation, it also provides templates for RNA synthesis.4 It is also 
found that DNA structures can be modified by a variety of chemicals which can 
interrupt normal base paring, leading to mutations of genes or even cause death to 
cells. Thus, selective modification of DNA with encoding genes that cause disease 
can be an effective medical treatment. DNA alkylation is one type of these 
modifications. 
DNA alkylation has attracted a lot of interest over the years because of its 
function as both carcinogens and anti-cancer agents. Some DNA alkylating agents are 
widely used as antitumor drugs in the clinic. Antitumor drugs usually involve both 
specific and non-specific interactions with a DNA duplex sequence, which codes for 
the protein related to the tumor, DNA repair, or transcription activation.5 These 
interactions either affect the protein that is crucial to cell growth or directly influence 
DNA synthesis. However, alkylation agents can also cause serious toxic effects to the 
normal cells. Therefore, it becomes essential to understand the detailed mechanism 
and reactivity of alkylating agents. 
There are three major types of DNA alkylation: monoalkylation, intrastrand 
crosslink, and interstrand crosslink (Figure 1.3). Monoalkylation is formed when 
alkylating agents have only a single reactive site and examples including small 
molecules like methyl iodide which will be introduced below. Alkylating agents with 




interstrand crosslinking depending on the position of the nucleophiles.6 Of all three, 
interstrand cross-linking is the most toxic of all alkylation events since it results in 
seizure of the replication fork which completely shut down the replication.7 
Therefore, the DNA interstrand cross-linking agents are significant clinical agents in 
the treatment of cancer and also other diseases such as psoriasis and various anemia.8 
mono-alkylation
or






Figure 1.3 Mechanistic pathways for DNA alkylation by interstrand cross-linking 
agents.5 
 
1.2 DNA alkylation agents 
DNA alkylating agents can be generated from a variety of biological and 
chemical process, or synthetic pathways.9,10 Two most common examples of the 
alkylating agents are methyl iodide and dimethylsulfate, which can react through SN2 




in the DNA. Due to their high reactivity, these molecules usually lack specificity and 
reversibility and will lead to difficulties in controlling their reactions. 
 
Figure 1.4 Structures of methyl iodide (1.1) and dimethylsulfate (1.2) 
 
DNA alkylating agents can also form reversible adducts with the nucleophiles 
in the DNA. Malondialdehyde (MDA), which is the mutagenic byproducts of lipid 
peroxidation, is such an example.10,11 MDA can form adducts with adenine and 
cytosine, but it reacts most readily with guanine to form a 1:1 adduct, pyrimido[1,2-
a]purin-10-(3H)-one, termed M1G. NMR studies of M1G in oligonucleotides suggest 
that it exists as the ring-opened form, N2-oxopropenylguanine (Scheme 1.1).12 But 
under heating condition, denaturation will initiate cyclization to form M1G again. 
Therefore, the products exist in an equilibrium between the ring closed and ring 
opened forms. The generation of this reversible alkylation product increased the 
toxicity of the alkylation process to the cell. Because the structures of the two adducts 
are so different, it is assumed that they have a significant difference in cytotoxicity. 
Thus, different pathways are required for DNA to repair this type of damage. As a 
result, chances become larger repair of DNA during replication and mutation fail 





Scheme 1.1 Cyclic and open chain β-hydroxyacrolein adducts of dG.13 
 
Cyclopropyl alkylating agents is another example that could form reversible 
alkylation adducts. These include members such as the duocarmycins and CC-1065 
(Figure 1.5). The bases of DNA react with these compounds by nucleophilic attack on 
the cyclopropyl ring. It then opens the ring and restores the aromaticity to an adjacent 
ring system. In the case of duocarmycins, alkylation reaction is reversible. This near 
thermal neutral reaction was stabilized by extensive noncovalent binding interactions 
derived from hydrophobic binding and van der Waals contacts.14 The reversible 
alkylating agents are believed to have more potential applications than irreversible 
alkylating agents because the reversible alkylating agent can be regenerated and 
realkylate the DNA after its adducts are excised from DNA.15,16  Therefore, study of 






Figure 1.5 Structures of well known cyclopropyl alkylating agents. 
 
1.3 Quinone Methides (QMs) and reversible alkylation of DNA 
Quinone methide (QM) and its derivatives are a class of reactive intermediates 
that widely occur in phenol chemistry and biological metabolism.17 QMs are 
structurally related to benzoquinones with one of the carbonyl oxygens replaced by a 
methylene group. This structural change makes them highly electrophilic 
intermediates and the exo-double bond readily reacts with nucleophiles. There are 
generally two types of quinone methides: o-QM and p-QM (Figure 1.6). These 
transient intermediates can be generated through activation of quinone methide 
precursors (QMP).  Methods of activation include heat,18 UV radiation,19-21 
































Figure 1.7 Methods of QM generation. 
 
QM is also regarded as a potential anticancer treatment. Nucleophiles such as 
DNA bases can attack the exocyclic double bond of QM, pushing the electron back to 
the ring to restore its aromatic system. Mitomycin C is one example of QM alkylating 
agents approved for use as an anticancer drug.26 It can be reductively activated to 




from DNA react with the electrophilic site yielding a mono-adduct (Compound 1.4). 
After releasing another leaving group, the nucleophilic sites in the DNA react with 
the newly formed double bond to form a cross-linking product (Compound 1.6).26 
Mitomycin C usually alkylates DNA at dG N7 position.27 However, toxic side effects 
have also been observed mainly caused by non-specific reactions.27,28  
 




A series of silyl ether protected quinone methide precursors was developed by 
the Rokita lab. These QMPs can be activated in the presence of fluoride ion (Figure 
1.9).29,30 The o-QM precursor usually has a bromide or an acetate group as the leaving 
group. The QMP can be delivered to the specific target site by coupling to the site-
directing ligand to improve the alkylation specificity.31 This alkylation process will be 





Figure 1.9 Activation of QMP and its function as alkylation reagent. 
 
Comprehensive studies have been performed in Rokita lab to investigate the 
reactivity and selectivity of QM with nucleophilic sites in the DNA. Experimental 
results showed that the formation of the QM alkylation adduct may be actually 
reversible.32 Model QM studies showed that QM reacts with strong nucleophiles such 
as dA N1 and dG N7 quickly but reversibly.29 The quickly formed adducts are not 
stable and will regenerate QM readily. The reactions of QM with weak nucleophiles 
such as dG N1, dG N2 and dA N6 are slow but irreversible (Table 1).33 The 
reversibility of the alkylation by QM is significant because reversible alkylating 
agents can be regenerated from the non-specific binding adducts and finally associate 
with target nucleophiles to form the thermodynamic products. The reversibility of the 
alkylation  increases the half life of this highly transsient intermediate in the reaction 
solution.34 It also provides us an alternative way to generate the QM without using 














































dA N6 adduct dG N2 adduct dG N1 adduct  
Table 1.1 Reversible and irreversible adducts formed with deoxynucleotide by QMP. 
 
1.4 Substituent’s effect on the kinetics of QM alkylation 
 To further understand the alkylation activity of the QMP with 
deoxynucleotides, aromatic substituent effects were studied. Alkylation adducts were 
generated with QMP containing different substitution groups and the stability of the 
adducts were tested.35 The dC adduct formed by QMP with an electron donating 
methyl substituent reached its maximal yield in less than 1 hour, while the half life of 
releasing dC was around 5 hours (Figure 1.10).35 In the contrast, an electron-
withdrawing group present in the quinone methide precursor suppresses both initial 
formation of the QM and regeneration of QM from its dC adduct. The methyl ester 
QM was generated over 40 hours and the formed dC adduct was stable for more than 
24 hours. Unsubstituted QMP-dC adducts showed a moderate stability, with the half 




deficient property of the QM intermediate. Therefore, QMP with an electron donating 
group should accelerate its reaction with the nucleophiles which are studied in later 
chapters.  
 
Figure 1.10 Structures of substituted QMP and formation and decomposition of 
quinone methide adducts of dC N3. Plot was taken from the literature.36 
 
 
1.5 Target promoted alkylation by DNA-QMP conjugates 
Selective alkylation of DNA by QM can be achieved by coupling the QMP to 
a site-directing agent.31This target promoted alkylation process was designed based 
on the reversible reaction of QM with nucleobases. The QMP was first coupled to a 
single strand DNA. Then the QM was generated from a precursor by adding fluoride.  
The QM then reacted with bases in the DNA strand to form QM-oligonucleotide self-
adducts. When a complementary strand (the target sequence) was added to this QM-
oligonucleotide self-adduct, the QM could be regenerated from the reversible self-




produce the interstrand cross-linking adduct (Figure 1.11). This process allows QM to 
be selectively delivered to a specific target sequence for alkylation and minimize 
toxicity caused by alkylation agents lacking of selectivity. Previous results showed 
that the cross-linking of this process is very specific. However, maximal alkylation 
requires a 7 days incubation.31  
Figure 1.11 Target promoted alkylation by ssDNA linked QM. 
 
1.6 Triplex-forming oligonucleotides (TFO) as a delivery agent for alkylation of 
double strand DNA 
DNA duplex can form a stable structure with a third strand. The formation of 
such a triple-helical nucleic acid structure was first observed in 1957.37 It happens 
when a single strand DNA/RNA binds to a homopurine or homopyrimidine region of 
the duplex DNA.  The third strand is normally described as a triplex-forming 
oligonucleotide (TFO) and binds specifically in the major groove of the duplex DNA 
(Figure 1.12). The structure is stabilized through Hoogesteen or reverse Hoogesteen 





Figure 1.12 Schematic representation of DNA triplex formation. The purine and 
pyrimidine strands are shown in blue and yellow respectively. The TFO indicated in 
red binds to the purine-rich strand of the target duplex through the major groove. 
Figure was copied from the literature.38 
 
A TFO can be either a poly-pyrimidine or a poly-purine sequence. The TFO 
that consists of cytosines (C) and thymines (T) binds parallel to the purine-rich strand 
of DNA through Hoogesteen bonds. In this case, the cytosines in the third strand need 
to be protonated at N3 position for hydrogen bond with N7 of guanine. Therefore, this 
type of triplex only occurs under acidic condition. It could not bind to double strand 
DNA under physiologic condition without further modification.39 The purine motif 
binds to the purine rich strand in an antiparallel orientation. The binding is through 
reverse Hoogsten base pair and no base protonation is required.40 Thus, this triplex 





Figure 1.13 Hoogesteen and reverse Hoogesteen hydrogen bonding formed in the 
triplex. 
 
Triplex formation is sequence and length dependent. Studies showed that at 
least 12-14 uninterrupted purines are needed to achieve adequate triplex binding.41 A 
single interruption in the polypurine sequence can significantly destabilize triplex 
formation. However, once the triple helix structure is formed in the homopurine/ 
pyrimidine region, it is quite stable in the presence of divalent cations such as Mg2+, 
Ca2+, Zn2+and naturally occurring polyamines which reduce the electrostatic repulsive 
forces between the negatively charged strands.37,42 As a result, TFO is considered as 
an effective tool in gene targeting based on its stability and specific binding. TFO can 




inactivate it. There are abundant TFO binding sites in mammalian genomes and a lot 
of them are in the promoter and/or transcribed gene regions.43 A variety of chemical 
modifications of the DNA strands are also available to improve a strand’s affinity for 
the duplex DNA. Therefore, the triple helical structure provides an effective tool to 
manipulate duplex DNA. 
One example of this application is to use TFO as a site delivery agent for 
alkylation agents to the target duplex DNA. Seidman’s group reported an Hprt knock-
out assay to measure the activity of TFOs linked to the DNA cross-linker psoralen.44 
The photo-activated molecule successfully cross-linked the target duplex sequence 
through triplex formation and the subsequent mutation activity of that specific gene 
was analyzed.  
In order to apply QMs for alkylating duplex DNA, a reactive QMP must be 
produced to speed up the alkylation process. Currently, alkylation of the DNA is too 
slow to take effect in the biological system. This dissertation will focus on design and 
synthesis of a more reactive QMP with increased electron density compared to the 
conventional QMP. Both QMPs were coupled to single strand DNA and their DNA-
QM self-adducts formation was investigated and compared. Alkylation of the single 
strand DNA target and double strand DNA target using both self-adducts was studied. 
The electron rich QMP improved alkylation efficiency of the target promoted 
alkylation process. It also prepared the QM for further application of its alkylation 




 Chapter 2: Design and synthesis of an electron rich quinone  
methide precursor 
2.1 Introduction 
Inspired by the reversible nature of QM alkylation,45,46 a DNA-QM complex 
was delivered to a specific DNA sequence for alkylation. Previous results indicated 
that the yield of the single strand alkylation by the DNA-QM complex reached its 
maximal after a 7-day incubation.31  This indicated a slow process of DNA alkylation 
by the DNA-QM self-adduct. As a result, the current QM will not be very efficient if 
developed to treat disease. The slow reaction speed will also limit the QM alkylation 
ability of a target DNA in the biological system because DNA repair may fix the 
cross-linking part before it affects the DNA activity. Therefore, it is necessary to 
design a more reactive QMP than the previous one to speed up the alkylation. The 
increased alkylation rate would help optimize the QM alkylation ability for a 
biological application. 
The structure of the original quinone methide precursor (QMP1) used by our 
group is showed in Figure 2.1. In this precursor, an acetate group is the leaving group 
for QM formation. The N-hydroxylsuccinimide ester included in the molecule is 
designed to activate the carboxylic acid group for coupling to the terminal amine 
linker of a synthetic DNA. Kinetic study of QMP1 indicated that the rate determining 
step of QM generation from its precursor was the elimination of the acetate group 




generation can be increased by speeding up the elimination step which will eventually 
accelerate the target promoted alkylation. According to previous results, an electro-
donating group present in the molecule will facilitate the generation of the QM from 
the precursor and its regeneration from the reversible alkylation adduct.35  Therefore, 
a pair of electron rich quinone methide precursors were designed and their structures 
are showing below (Figure 2.1, QMP* and QMP2). QMP* has the same structure as 
QMP1 except for a methoxy group on the para position with respect to the benzylic 
acetate group.  In QMP2, the ester linker is moved to the para position to the acetate 
group and an oxygen atom is used to replace a carbon of the linker. These 
modifications can increase the electron density of the molecule to facilitate the 
elimination of the acetate group and maintain the alkylation function of the 
moleculre.  Multiple synthesis routes were tried to produce QMP* and QMP2. This 
chapter will focus on the design and synthesis work and towards these two desired 
QMPs. 
 
Figure 2.1 Structures of original (QMP1) and electron rich (QMP* and QMP2) 






2. 2 Results and Discussion 
2.2.1 Synthesis of QMP1  
QMP1 was previously synthesized in our laboratory.31 The synthetic 
procedure was followed with slight modification (Figure 2.2). In the original 
literature, compound 1 was generated in sodium salt form and was used directly for 
the next step without any purification. The overall yield for the two steps was 13%.31 
Modification was made to this step because salt form of sodium salt form of 1 had 
similar polarity with compound 2 which made the separation of the protection 
reaction difficult. Therefore, compound 1(acid form) was produced and purified after 
the first step. Separation of protected product 2 from the reactant 1 was easy to 
achieve due to their different polarity without influencing the yield (15% for two 
steps). Finally, QMP1 was isolated and characterized by proton NMR to confirm its 
formation.  
 




2.2.2 Attempts for synthesis of QMP*  
QMP* was initially designed as the electron rich target molecule. An electron 
donating methoxy group was added to QMP1 to increase the electron density of the 
molecule while the rest of the structure stayed the same to function as a QMP. Several 
attempts to synthesize this compound have been made. In the first attempted synthesis 
(Figure 2.3), 7-hydroxycoumarin was used as the starting material. This molecule 
could provide the substitutions on the desired positions of the benzene ring to 
construct the target molecule after the lactone ring was opened. The hydroxyl group 
was first protected by reacting with TBDMSCl in the DMF (dimethylformamide) 
following a standard procedure47 (72% yield), the double bond of the lactone ring of 
compound 4 was reduced through hydrogenation to yield compound 5 in 87%. Ring 
opening and methylation of the nascent hydroxyl group was achieved in one step 
using dimethyl sulfate and sodium hydride.48 Reaction was completed within 4 hours 
under room temperature to produce compound 6 with a 52% yield. Then compound 6 
was deprotected with tetra-n-butylammonium fluoride (TBAF) under standard 
conditions49 to yield compound 7 in 86%. The removal of the phenol protecting group 
was necessary since the coupling of benzylic hydroxyl group can only be achieved 
with the phenol substrate 7 rather than compound 6. Previously, this step was 
accomplished by heating up the phenol substrate 3-(4'-hydroxyphenyl)-propionic acid 
with formaldehyde under basic condition.31 Compound 1 was produced as the major 
product. However, the reaction worked differently in the presence of methoxy group 
on the starting material. No desired product (compound 8) was ever detected when 




TLC (Thin Layer Chromatography) results indicated that the starting material was 
quickly consumed during the reaction without forming any major products. 
Polymerization was likely under this condition since this reaction could evolve into 
chain reaction to produce Phenol-Formaldehyde resins (PF resins).50 The same 
reaction was repeated without heat and using mild base CaO. This eliminated the 
formation of the byproducts, but no desired product was observed either.51 
 
Figure 2.3 First attempt for synthesis of QMP*. 
 
In order to avoid the difficulty brought by adding the methyl alcohol group to 
the electron rich substrate, a second synthetic route was designed starting with a 
benzyl aldehyde substrate (Figure 2.4). In this case, the target benzyl alcohol group 




to the benzene. The commercially available 2-hydroxy-4-methoxybenzylaldehylde 
was first brominated to produce compound 9. Product was purified through 
recrystallization resulted in a final yield of 81%. A Heck reaction was then used to 
couple methyl acrylate to the benzene ring to construct the linker. Palladium acetate 
and 1,3-bis(diphenylphosphino)propane (dppp) were used as catalysts and 
triethylamine as the base for this coupling. The reaction mixture had to be maintained 
under inert gas with anhydrous reagents to produce the product in a 21% yield. The 
next step was to reduce the double bond of compound 10. However, the aldehyde 
group was also reduced to methyl group under hydrogenation for double bond 































































2.2.3 Attempts for synthesis of QMP2  
Based on my synthetic work, it was difficult to produce the model QMP 
structure in the presence of the added methoxy group. Upon Dr. Isaacs’s suggestion, 
we modified our target molecule to simplify the synthetic process by eliminating the 
extra functional group on the benzene ring. A second electron rich quinone methide 
precursor (QMP2) was designed using oxygen atom to replace the carbon atom of the 
ethyl carbon chain of the linker. The QM linker was moved to the para position away 
from the benzylacetate group. As a result, the electron density of the molecule was 
increased without adding an extra functional group. Reposition of the linker would 
not affect its function to attach the precursor to a site-directing ligand.  
The initial synthesis of QMP2 started with commercially available 2,4-
dihydroxybenzaldehyde and its reaction with methyl bromoacetate to couple the 
linker to the 4-hydroxy group of the ring (Figure 2.5).52 This reaction was selective 
for the 4-hydroxy group. The isolated mono-alkylation product was confirmed as 
methyl 2-(4-formyl-3-hydroxyphenoxy)acetate (compound 12) by 2D NMR showing 
all corresponding C-H (Heteronuclear Single Quantum Coherence, HSQC) and C-C 
(Heteronuclear Multiple Bond Correlation, HMBC) correlations. This selectivity was 
likely to be the result of the hydrogen bonding between the oxygen atom of the 
carbonyl group and the proton of its neighboring phenol hydroxyl group (Figure 2.6). 
The increased pKa of the 2-hydroxyl proton made it hard to be removed compared to 
the proton of the 4-position hydroxyl group.28 This hydrogen bonding was also 
indicated by correlation between the carbonyl carbon and the phenol proton showed 




was refluxed for more than 6 hours, there was still starting material left but the 
disubstituted product started to appear based on TLC. The disubstituted product was 
less polar than compound 12 and its structure was confirmed by proton NMR. So 1 
equivalent of methyl bromoacetate was used minimize the formation of disubstuited 
byproducts and the desired compound 12 was yielded in 40%. If the unreacted 
starting material was recovered during purification, the yield can increase to 56%.  
 






Figure 2.6 Intra-molecular hydrogen bonding of compound 12. 
The reduction of the aldehyde of compound 12 was carried out using borane-
tetrahydrofuran (BH3-THF) complex. This reducing reagent was selected because it 
would not affect the carbonyl group of the methyl ester. A single product 13 was 
produced through this reaction in a 83% yield. The hydroxyl groups were then 
protected by TBDMS through a standard procedure.47 The methyl ester in the linker 
was then hydrolyzed to the desired carboxylic acid group. Potassium carbonate was 
first tried for this reaction since it appeared to be inert to the TBDMS group when 
synthesizing compound 2. However, multiple products were evident by TLC resulting 
in very polar product. This indicated the TBDMS group was also removed during the 
hydrolysis. Potassium trimethylsilyanolate was then used for the hyrdrolysis. This 
mild base showed to be very inactive towards the silyl protecting group because of 
the steric hindrance of this bulky nucelophile.53 However, compound 15 was 
produced in 65% instead of the expected compound 16 and confirmed by the NMR 
data with a missing set of TBDMS peak. This result indicated that the TBDMS group 
in this electron rich substrate was very sensitive to hydrolysis. The phenol group 
required protection again to form compound 16. This was accomplished by a 
literature procedure using TBDMSCl with a 64% yield. 
The next step was to replace the benzylic TBDMS with the acetate. 




reaction that was  developed by the Ganem’s group.54 This method was applied in 
QMP1 synthesis to produce compound 6 successfully. The reaction was tried on the 
electron rich substrate 16 using various reaction conditions (Table 2.1). The desired 
compound 17 was never identified but the starting material 16 could be isolated from 
the reaction mixture. This result indicated that compound 16 did not react with the 
acetic anhydride to form the target compound in the presence of iron chloride. A 
different Lewis acid Cu(OTf)2 was also tried without yielding the expected polar 
product on the TLC. Therefore, the synthesis route had to be modified to avoid the 







0.15 Acetic anhydride (Ac2O) 
0 oC 30 min No product spot observed on TLC 
0.3 Ac2O 0 oC 30 min 
No product spot 
observed on TLC 
Excess Ac2O 0 oC 1 h 
No product spot 
observed on TLC 
Excess Ac2O -40 oC 4 h 
Starting material 
remained, no product 
spot observed on TLC 
Excess Ac2O/CH2Cl2 -40 oC 4 h 
Starting material 
remained, no product 
spot observed on TLC;  
Excess Ac2O -15 oC 4 h 
Starting material 
remained, no product 
spot observed on TLC 
Excess Ac2O 20 oC 4 h 
Starting material 
remained, no product 
spot observed on TLC 
Excess Ac2O 40 oC overnight 
No starting material left, 
no product spot 
observed on TLC 
Table 2.1 Reaction conditions and results for FeCl3 catalyzed TBDMS conversion 





2.2.4 The final synthesis of QMP2 
The final synthesis plan (Figure 2.7) also started with 2,4-dihydroxy 
benzaldehyde to generate compound 12 by reacting with methyl bromoacetate. 
Different from the synthesis route discussed above, the aldehyde group was reduced 
in the later stage after the phenol group was protected. Then the resulting hydroxyl 
group was converted to acetate through esterification. This avoids the Lewis acid 
catalyzed conversion from the TBDMS protected hydroxyl group to acetate.    
The methyl ester group of compound 12 was hydrolyzed using potassium 
trimethylsilylanolate to yield a single product 18 in 75%.55 In the initial synthesis plan 
for this target molecule, the ester group was kept until the final stage for convenient 
handling during purification. However, we found that the phenol TBDMS protecting 
group was very unstable to hydrolysis. Thus, the carboxylic acid derviative was 
generated at an early stage and used for later reactions. The acid compound 18 was 
prepared by hydrolyzing its ester precursor 12, which required two steps from the 
commercially available starting material, rather than coupling the acetic acid 
derivative directly to 2,4-dihydroxybenzaldehyde which required only one. This was 
because direct coupling yielded multiple products; the desired product could never be 
isolated. After purifying compound 18 by recrystallization, the phenol hydroxyl group 
was protected by TBDMS group using triethylamine (TEA) as the base and 4-
dimethylaminopyridine (DMAP) as the catalyst to produce compound 19.56 Standard 
condition for the protecting reaction that included imidazole as the base but this only 
resulted in a less than 10% yield of 19. This low yield might be caused by the 




without an intermolecular hydrogen bonding. The reaction mixture was stirred in dry 
DMF under room temperature and nitrogen atmosphere for 20 hours. Compound 19 
was then isolated after column purification in a yield of 42%. In addition to the higher 
conversion yield using this catalytic protecting condition compared to the standard 
condition, this condition also showed an interesting selectivity by not producing the 
TBDMS-ester intermediate observed previously.57 The hydroxyl group of the 
carboxylic acid was also protected with TBDMS under standard condition when 
synthesizing compound 2. This ester bond was labile and could be hydrolyzed under 
acidic condition. In that case, the crude product had to be treated with acid to remove 
the unwanted protecting group. Protection reaction using DMAP and TEA did not 
require this extra step since TBDMS group was selectively added to the phenol group. 
 





Sodium borohydride was then used to reduce the aldehyde group. The 
reducing agent was chosen to avoid possible reaction with the carbonyl group of the 
carboxylic acid. Compound 20 was formed quantitatively and the crude material was 
ready to use for the next reaction.56 The acetate group was introduced through 
esterification of the benzylic alcohol with acetic anhydride using DMAP as the 
catalyst to form compound 17 in a yield of 71%.  Finally, the N-hydroxysuccinimide 
was coupled to compound 17 to following a procedure published previously.31 The 
target electron rich quinone methide precursor QMP2 was isolated with a yield of 
48% (single step yield) and ready to couple to DNA sequences. 
2.3 Conclusion 
In order to increase the alkylation speed efficiency by a DNA-QM species, 
two electron rich quinone methide precursors were designed. The increased electron 
density from the electron donating group can promote generation of the QM from its 
precursor.35 As a result, subsequent alkylation should also be accelerated. Two 
synthetic plans were tried to construct the target molecule QMP* but neither were 
successful. The major difficulty in this synthesis derived from constructing the benzyl 
alcohol structure and handling this reactive intermediate. Although 
hydroxymethylation proceeded easily for a substrate without electron donating 
groups, all attempts to repeat this procedure with an electron rich substrate 
(compound 7) failed. Multiple products were evident and the desired product was 
never isolated. Another precursor QMP2 was then designed to simplify the synthetic 
procedure. Two more synthetic routes were planned for this molecule. First, the 




for later conversion to benzyl alcohol through reduction. This design avoided the step 
of directly adding the methylhydroxyl group to the molecule. The first synthetic 
attempt for QMP2 failed at the final stage, for which the TBDMS group protected 
benzyl hydroxyl could not be converted to the desired acetate using a Lewis acid 
catalyzed reaction. To avoid this particular reaction, a second synthetic route was 
designed. In this plan, the acetate group was produced through esterification of the 
methyl hydroxyl group with acetic anhydride. This modification in the synthetic plan 
finally led to the successful synthesis of the target molecule QMP2.   
2.4 Materials and methods 
General materials  
Reagents, starting materials, solvents and salts of the highest commercial 
grade were used without further purification. All aqueous solutions were prepared 
with distilled, deionized water with a resistivity of 18.0 MΩ. Silica gel (230-400 
mesh) for column chromatography was purchased from EM Sciences. All deuterated 
solvents for NMR spectroscopy were purchased from Cambridge Isotope 
Laboratories. 
General methods 
Melting points were measured with a Thomas-Hoover Unimelt apparatus that 
was not corrected.  NMR spectra were recorded on a Bruker AM400 spectrometer 
and Bruker DRX-500 high resolution spectrometer and referenced to residual protons 
in the deuterated solvents.  Chemical shifts (δ) are reported in parts per million (ppm).  
Coupling constants (J) are reported in hertz (Hz).  Mass spectra were determined 





Synthetic procedure of QMP1 was adapted from the original preparation 
method in the literature with modification in purification step. All the compounds 
were characterized by proton NMR and the data were consistent with the 
literature.31,57 
 
3-[3-Hydroxymethyl-4-hydroxyphenyl]propionic acid (1). A aqueous solution of 
NaOH (10%, 5 ml) was added to 3-(4-hydroxyphenyl)propionic acid (2.0 g, 12 
mmol) solid to adjust the pH to 8. Then, a formaldehyde aqueous solution (37%, 5 
mL) was added dropwise, and the mixture was heated at 60° C for 16 hours. The 
reaction mixture was cooled to room temperature and 1 M HCl was added to adjust 
the pH to 3. The resulted solution was extracted with ether (3×50 ml). The organic 
layer was collected, dried over sodium sulfate and evaporated with a rotoevaporator. 
The crude product was purified by silica gel chromatography (hexane : ethyl acetate = 
2 : 1 and 0.5% HOAc) and yielded product 1 as a faint white solid (491 mg, 21.2%).  
1H NMR (400 MHz, D2O) δ 2.52 (d, J=8, 2H), 2.72 (t, J=8, 2H), 4.48 (s, 2H), 6.72 (d, 
J=8, 1H), 6.96 (d, J=8, 1H), 7.04 (s, 1H).   
3-[3-tert-Butyldimethylsilyloxymethyl-4-tert-butyldimethylsilyloxyphenyl]- 
propionic acid (2). To a solution of compound 1 (490 mg, 2.52 mmol) in DMF (5 
ml), t-butyldimethylsiyl chloride (TBDMSCl, 2.26 g, 15.1 mmol) and imidazole (2.03 
g, 30.2 mmol) were added and stirred under room temperature for 18 hours. Brine 
was then added to dilute the solution which was extracted by diethyl ether (3×15ml). 




was then filtered and evaporated to yield crude product. The crude was redissolved in 
10 ml MeOH and potassium carbonate (556 mg, 4.03 mmol) was added. The solution 
was stirred under room temperature for 3 hours. Upon completion of reaction, 0.1 M 
HCl was added to adjust the solution to pH 3. The mixture was then diluted with 
water and extracted with ether (50 ml ×3). The organic phases were combined, 
washed with brine, dried over NaSO4, and concentrated under reduced pressure.  The 
residue was purified by silica gel chromatography (hexane: ethyl acetate= 5:1) to 
yield 2 as a colorless oil (770 mg, 73%). 1H NMR (400 MHz, CDCl3) δ 0.09 (s, 6H), 
0.18 (s, 6H), 0.94 (s, 9H), 0.98 (s, 9H), 2.63 (t, J= 8, 2H), 2.87 (t, J= 8, 2H), 4.71 (s, 
2H), 6.66 (d, J= 8 1H), 6.92 (d, J= 8, 1H), 7.26 (s, 1H).   
3-[3-Acetoxymethyl-4-tert-butyldimethylsilyloxyphenyl]propionic acid (3). Solid 
ferric chloride (9 mg, 0.06 mmol) was added to a solution of 2 (191 mg, 0.452 mmol) 
in acetic anhydride (3 mL) at 0 °C.  The reaction mixture was stirred for 30 minutes 
and then diluted with 30 ml ether.  The resulted solution was washed with water and 
saturated aqueous NaHCO3. The organic phase was dried over NaSO4, and 
concentrated under reduced pressure.  The residue was subjected to silica gel 
coloumn chromatography (hexane: ethyl acetate= 3:1) and yielded 3 as a colorless 
liquid (63 mg, 40%).  1H NMR (400 MHz, CDCl3) δ 0.18 (s, 6H), 0.94 (s, 9H), 2.06 
(s, 3H), 2.69 (t, J= 8.0, 2H), 2.86 (t, J= 8.0, 2H), 5.03 (s, 2H), 6.70 (d, J= 8.0, 1H), 
6.99 (d, J= 8, 1H), 7.09 (s, 1H).  
N-Succinimidyl-3-(3-acetoxymethyl-4-tert-butyldimethylsilyloxyphenyl) 
propionate (QMP1). N-Hydroxysuccinimide (34 mg, 0.32 mmol) was added to a 




to 0 °C in ice and 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide (EDCI, 48 mg, 
0.25 mmol) was added in one portion. The mixture was first stirred under 4 °C for 2 
hours and then warmed up and maintained at room temperature for 21 hours. After 
the reaction completed, the solution was diluted with brine and extracted with ether 
(3×15 ml).  The organic phases were collected, dried over NaSO4 and concentrated 
under reduced pressure.  The residue was purified by silica gel column 
chromatography (hexane: ethyl acetate=3:1) to yield QMP1 as a clear oil (49 mg, 
61%).  1H NMR (400 MHz, CDCl3) δ 0.18 (s, 6H), 0.94 (s, 9H), 2.06 (s, 3H), 2.62 (s, 
4H), 2.69 (t, J= 8.0, 2H), 2.86 (t, J= 8.0, 2H), 5.03 (s, 2H), 6.70 (d, J= 8.0, 1H), 7.00 
(d, J= 8, 1H), 7.10 (s, 1H).  
7-tert-Butyl(dimethylsily)oxycoumarin (4).47 To a solution of 7-hydroxycourmain 
(1.6 g, 10 mmol) in DMF (25 ml), t-butyldimethylsiyl chloride (TBDMSCl, 1.8 g, 12 
mmol) and imidazole (1.6 g, 24 mmol) were added and stirred under room 
temperature for 6 hours. Brine was then added to dilute the solution. The mixture was 
washed using ether (3×15ml).The organic layer was collected and dried with sodium 
sulfate. Solvent was then evaporated to yield crude solid product. The product was 
purified using silica gel chromatography with hexane and ethyl acetate (5:1) to afford 
a white solid in 72% yield. 1H NMR (400 MHz, CDCl3) δ0.23 (s, 6H), 0.97 (s, 9H), 
6.24 (d,  J=9.6, 1H), 6.75 (m, 2H), 7.31 (d, J=8.0, 1H), 7.61 (d, J=9.6, 1H); 13C NMR 
(100 MHz, CD3CN) δ -4.9, 18.3, 25.3, 107.8, 113.6, 113.9, 129,7, 144.1, 156.0, 
159.4, 161.0; m/z (ESI+): 277.9, calculate (M+H+): 277.1; m.p.: 64~66 oC.  
7-tert-Butyl(dimethylsily)oxy-(2H, 3H)coumarin (5). The procedure was adapted 




dissolved in 60 ml absolute ethanol and then 10% palladium/carbon (0.50 g) was 
added to the solution. The mixture was shaken under hydrogen atmosphere (50 psi) in 
the Parr hydrogenator at room temperature for 22 h, after which the catalyst was 
filtered off and washed with ethanol. The filtrate was concentrated in vacuo and crude 
product was purified through silica gel chromatography using a mixture of hexane 
and ethyl acetate (7:1) as eluent to afford a white solid in 87% yield. 1H NMR (400 
MHz, DMSO-d6) δ0.17 (s, 6H), 0.95 (s, 9H), 2.74 (t, J=7.1, 2H), 2.91 (t, J=7.1, 2H), 
6.55 (m, 2H), 6.99 (d, J=8, 1H,); 13C NMR (100 MHz, DMSO-d6) δ-3.7, 18.8, 23.0, 
26.4, 29.6, 108.7, 116.5, 117.0, 129.7, 153.0, 155.5, 169.1; m.p.: 40~42 oC. 
Methyl 3-(2-methyloxy-4-tert-butyl(dimethylsily)oxybenzen)propionate (6). The 
procedure was adapted from the literature with modification.48 To a solution of 5 
(0.83 g, 2.5 mmol) in THF (25 ml) was added sodium hydride (60% in mineral oil, 
1.0 g). The mixture was stirred at room temperature for 1 hour and then 
dimethylsulfate (2.37 ml, 14.1 mmol) was added. After stirring the mixture for 
another 3 hours at room temperature, 20 ml water was added to dilute the solution. 
Chloroform was used for extraction (3×15ml) and the collected organic phase was 
washed with 10% aqueous NaOH. Magnesium sulfate was used to dry the organic 
phase. Product was concentrated in vacuo yielding a yellow oil. Purification was 
achieved through silica gel chromatography with hexane and ethyl acetate (7:1) to 
afford a transparent liquid in 52% yield. 1H NMR (400 MHz, DMSO-d6) δ0.14 (s, 
6H), 0.90 (s, 9H), 2.45 (m, overlap with solvent peak), 2.67 (d, J=7.6, 2H), 3.53 (s, 




NMR (100 MHz, DMSO-d6) δ-3.6 18.8, 25.7, 26.5, 34.4, 52.1, 56.1, 104.1, 111.7, 
121.9, 130.6, 155.6, 158.7, 173.8. 
Methyl 3-(2-methyloxy-4-hydroxybenzen)propionate (7). The procedure was 
adapted from the literature.49 To a solution of 6 (0.572 g, 1.58 mmol) in THF (6 ml) 
was added TBAF/THF (1.0 M, 4 ml). The mixture was stirred for 1 hr at room 
temperature and then diluted with water. Ethyl acetate (3×10 ml) was used to extract 
the mixture and the collected organic phases were dried with magnesium sulfate. 
After removing the solvent under reduced pressure, product was purified with silica 
gel chromatography using hexane and ethyl acetate (7:1). The purified product was 
isolated as clear oil in 87% yield. 1H NMR (400 MHz, DMSO-d6) δ2.43 (m, overlap 
with solvent peak), 2.64 (t, J=8, 2H), 3.52 (s, 3H), 3.67 (s, 3H), 6.21 (dd, J=8.2, 2.2, 
1H), 6.32 (d, J=2.4Hz, 1H), 6.83 (d, J=8Hz, 1H,). 
5-Bromo-2-hydroxy-4-methoxybenzaldehyde (9).51 2-Hydroxy-4-
methoxybenzaldehyde (0.91 g, 6.1 mmol) was dissolved in methylene chloride (8 ml) 
and cooled in an ice/water bath. Bromine (1.0 g, 6.6 mmol) in methylene chloride 
soultion (0.3 ml) was added to the cooled solution dropwise. The solution was stirred 
in an ice bath for 3 hours and then warmed to room temperature and stirred for 
another hour. Sodium bicarbonate solution (10%) was then used to wash the organic 
phase (3×10 ml). Then the organic layer was dried with sodium sulfate and 
concentrated to a yellow solid 0.93 g. After recrystallization (ethyl acetate/hexane, 
1:10), a white solid was obtained in 81% (1.12 g). 1H NMR (400 MHz, CDCl3) δ 3.93 




232.9, Calculated (M+: 231.0); m.p.: 118~120 oC. Data agreed with the literature 
value.  
Methyl 3-(2-methoxy-4-hydroxy-5-formylphenyl)acrylate (10). The procedure was 
adapted from the literature with modification in the amount of reagent used.59 
Compound 9 (0.28 g, 1.0 mmol), Pd(OAc)2 (0.022 g, 0.010 mmol) and 1,3-
bis(diphenylphosphino)propane (0.082 g, 0.020 mmol) were dissolved in anhydrous 
DMF (2 ml, purchased from Aldrich) in a round bottom flask. Distilled triethylamine 
(0.45 ml) and methyl acrylate (0.26 mg, 3.0 mmol) were then added to the solution. 
The reaction was heated to 110 oC for 20 hours under N2 gas. Ethyl acetate was added 
to the mixture after completion of the reaction (15 ml) to dilute the mixture and 2N 
HCl was added to make the mixture acidic (pH~3). The organic phase was washed 
with brine (3×25 ml), dried over sodium sulfate and evaporated to remove the 
solvent. The residue was subject to silica gel chromatography (Hexane: Ethyl 
acetate=5:2) to yield a white solid 0.051 g (21%). 1H NMR (400 MHz, CDCl3) δ 3.78 
(s, 3H), 3.93 (s, 3H), 6.46 (d, J=16, 2H), 6.44 (s, 1H) ( these two peaks are 
overlapped), 7.83 (d, J=16, 2H), 9.74 (s, 1H), 11.59 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 52.0, 56.6, 99.8, 115.3, 117.5, 117.9, 135.4, 139.0, 165.5, 166.0, 168.2, 
194.9; m/z (ESI+): 237.0, calculate (M+H+): 237.2; m.p.: 128~136 oC 
Methyl 2-(4-formyl-3-hydroxyphenoxy)acetate (12). To a solution of 2,4-
dihydroxybenzaldehyde (1.38 g, 9.98 mmol) in THF (50 ml), potassium carbonate 
(1.38 g, 9.98 mmol) was added in one portion.  The mixture was kept at 0 oC in an ice 
bath and methyl bromoacetate (1.0 ml, 10 mmol) in THF (5 ml) was added to the 




oC for gentle reflux for 6 hours.  Potassium carbonate was removed through filtration 
and solvent evaporated to yield a green oily liquid.  Purification was carried out 
through silica gel chromatography with methylene chloride and ethyl acetate (20: 1) 
to afford a white solid in 40% yield.  1H NMR (400 MHz, CDCl3) δ 3.80 (s, 3H), 4.66 
(s, 2H), 6.36 (d, J=2.4, 1H), 6.57 (dd, J=2.4, 8.4, 1H), 7.45 (d, J=8.8, 1H), 9.72 (s, 
1H), 11.43 (s, 1H); 13C NMR (400 MHz, CDCl3) δ 52.9, 65.4, 101.8, 108.9, 116.2, 
135.9, 164.7, 165.0, 168.6, 195.0; m/z (M+H+): 211.08, calculated 211.06; melting 
point: 91-92 oC. 2D NMR results are also available (HSQC and HMBC). All 
corresponding carbon hydrogen correlations of this molecule are showing in the 
spectra, which are attached as Figure 3 and Figure 4 in the appendix (Page 92, 93). 
Methyl 2-(3-hydroxy-4-(hydroxymethyl)phenoxy)acetate (13). To a solution of 12 
(631 mg, 3.00 mmol) in THF (20 ml), borane-THF complex (1.0 M, 3 ml) was added 
dropwise. The mixture was stirred on ice bath for 2 hours. Water (20 ml) was added 
in one portion to the solution to consume the excess borane. Ethyl ether (3×15 ml) 
was used to extract the solution and the combined organic phases were washed with 
brine (2×15 ml), dried over sodium sulfate and concentrated under reduced pressure 
to yield clear oil. This crude product was used directly and immediately for the next 
step. Crude yield: 1.1 g, 84%. 1H NMR (400 MHz, CDCl3) δ 3.78 (s, 3H), 4.58 (s, 
2H), 4.78 (2H), 6.38 (dd, J=4, 8, 1H), 6.44 (d, J=4, 1H), 6.91 (d, J=8, 1H), 7.4 (s, 
1H);  13C NMR (400 MHz, CDCl3) δ 52.7 (CH3), 64.6 (CH2), 65.6 (CH2), 103.5 (C), 
106.6 (C), 118.6 (C), 129.0 (C), 157.8 (C), 159.3 (C), 169.7 (C).  
Methyl 2-(3-tert-butyldimethylsilyloxy-4-(tert-butyldimethylsilyloxymethyl)-




tert-butyldimethylsilyl chloride (TBDMSCl, 1.52 g, 10.1 mmol) and crude product 13 
(1.1 g) in DMF (8 ml). The mixture was stirred under room temperature for 17 hours. 
Then brine (30 ml) was added to dilute the solution and ether (3×15 ml) was used for 
extraction. The combined organic phases were dried over sodium sulfate and 
concentrated under reduced pressure. The residue was then purified by silica gel 
chromatography (hexane: ethyl acetate, 4:1) to yield compound 17 as a clear oil (692 
mg, 52.4% over two steps). 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 6H), 0.19 (s, 6H), 
0.91 (s, 9H), 0.97 (s, 9H), 3.78 (s, 3H), 4.57 (s, 2H), 4.65 (s, 2H), 6.34 (d, J=4, 1H), 
6.47 (dd, J=4, 8, 1H), 7.30 (d, J=8, 1H); 13C NMR (400MHz, CDCl3) δ -4.9, -3.8, 
18.84, 18.85, 52.6, 60.6, 65.9, 106.2, 106.7, 126.2, 128.2, 153.3, 157.7, 169.9 
2-(3-Hydroxy-4-(tert-butyldimethylsilyloxymethyl)phenoxy)acetic acid (15).61 To 
a solution of 14 (202 mg, 0.458 mmol) in THF (3 ml), potassium trimethylsiylanolate 
(118 mg, 0.921 mmol dissolved in 2 ml THF) was added. The mixture was stirred in 
ice bath for 4 hours. Then 0.1 M citric acid solution was used to adjust the pH to 3. 
Water (10 ml) was then added to dilute the solution. The mixture was extracted with 
ether (3×10 ml), dried over sodium sulfate and concentrated under reduced pressure. 
The residue was then purified by silica gel chromatography (hexane: ethyl acetate, 
1:1) to afford the product as white solid. (265 mg, 64.8%). 1H NMR (400 MHz, 
CDCl3) δ 0.11 (s, 6H), 0.90 (s, 9H), 4.62 (s, 2H), 4.83 (s, 2H), 6.38 (dd, J=4, 8, 1H), 
6.44 (d, J=4, 1H), 6.84 (s, J=8, 1H); mass data was collected using negative 
ionization method; m/z (ESI-): 311.0 (M-H+), calculated: 311.1 
2-(3-tert-Butyldimethylsilyloxy-4-(tert butyldimethylsilyloxymethyl)phenoxy)-




butyldimethylsilyl chloride (TBDMSCl, 379 mg, 2.53 mmol) and product 15 (203 
mg, 0.650 mmol) in DMF (5 ml). The mixture was stirred under room temperature for 
1 hour. Brine (25 ml) was then added to dilute the solution and ether (3×10 ml) was 
used for extraction. The combined organic phases were dried over sodium sulfate and 
concentrated under reduced pressure. The residue was then dissolved in methanol (5 
ml) and potassium bicarbonate (65 mg) was added in one portion. The solution was 
stirred at room temperature for one hour and neutralized with 1M HCl. The mixture 
was diluted with water and extracted with ether (3×10 ml). The combined organic 
phases were washed with brine, dried over sodium sulfate and concentrated under 
reduced pressure. The residue was purified by silica gel chromatography (hexane: 
ethyl acetate, 2:1) to afford the acid product as white solid. (172 mg, 64%). 1H NMR 
(400 MHz, CDCl3) δ 0.06 (s, 6H), 0.19 (s, 6H), 0.90 (s, 9H), 0.91 (s, 9H), 4.59 (s, 
2H), 4.65 (s, 2H), 6.36 (d, J=2.4, 1H), 6.50 (dd, J=2.4, 8.8, 1H), 7.32 (d, J=8.4, 1H); 
13C NMR (400 MHz, CDCl3) δ -4.9, -3.8, 18.6, 18.8, 60.6, 65.4, 106.2, 106.7, 123.7, 
128.3, 153.4, 157.2. No significant carbonyl carbon peak was observed around 160-
200 ppm range due to the weak signal of the sp2 carbon on the spectrum.  
2-(4-Formyl-3-hydroxyphenoxy)acetic Acid (18). This procedure was adapted from 
the literature using a modified recrystallization procedure.62  Compound 12 (1.02 g, 
4.76 mmol) was first dissolved in THF (40 ml) and cooled to 0 oC in an ice bath.  
Potassium trimethylsiylanolate (1.83g, 14.3 mmol) was then added to the solution. 
The mixture was stirred on an ice bath for 4 hours until all of the starting material was 
consumed as monitored by TLC. Aqueous citric acid (0.1 M) was next used to adjust 




sulfate and concentrated under reduced pressure.  The crude solid was recystallized in 
hexane/ethanol (10: 1) to yield pure compound 2 as a white solid (0.694 g, 74.4%). 
1H NMR (400 MHz, CD3CN) δ 4.72 (s, 2H), 6.43 (d, J=2.4, 1H), 6.60 (dd, J=2.4, 8.6, 
1H), 7.59 (d, J=8.5, 1H), 9.75 (s, 1H), 11.34 (s, 1H); 13C NMR (125 MHz, CD3CN) δ 
65.9, 102.9 109.4, 117.2, 137.4, 165.3, 166.2, 169.8, 197.0; m/z (M+H+): 197.04, 
calculated 197.04; melting point: decomposed at 130 oC  
2-(3-tert-Butyldimethylsilyloxy-4-formylphenoxy)acetic Acid (19). To a solution 
of compound 18 (0.250 g, 1.27 mmol) in DMF (4 ml), triethylamine (0.90 ml, 6.4 
mmol) and DMAP (0.039 g, 0.32 mmol) were added.  tert-Butyldimethylsilyl 
chloride (TBDMSCl, 1.12 g, 7.61 mmol) was then added to the solution.  The mixture 
was stirred at room temperature under N2 atmosphere for 20 hours.  Then the reaction 
was diluted with water (20 ml) and extracted with ether (3×15 ml).  The combined 
organic phases were washed with brine (25 ml), dried over sodium sulfate and 
concentrated under reduced pressure.  The crude product was purified through silica 
gel chromatography with hexanes and ethyl acetate (2: 1, 1% acetic acid) to yield a 
white powder (42%, 0.167 g). 1H NMR (400 MHz, CD3CN) δ 0.26 (s, 6H), 1.00 (s, 
9H), 4.70 (s, 2H), 6.37 (d, J=2.4, 1H), 6.63 (dd, J=2.4, 8.8, 1H), 7.68 (d, J=8.8, 1H), 
10.23 (s, 1H); 13C NMR (125 MHz, CD3CN) δ -3.8, 19.4, 26.4, 66.1, 107.1, 110.4, 
123.3, 131.2, 161.8, 165.2, 170.1, 189.3; m/z (M+H+): 311.14, calculated 311.12; 
melting point: 114-115 oC 
2-(3-tert-Butyldimethylsilyloxy-4-(hydroxymethyl)phenoxy)acetic Acid (20).53  
Compound 19 (0.11 g, 0.35 mmol) was first dissolved in EtOH (5 ml) and cooled to 0 




solution in one portion.  The mixture was stirred in an ice bath for 2 hours until all the 
starting material was consumed as monitored by TLC. The solution was diluted with 
water (5 ml) and then placed under reduced pressure to remove EtOH.  The resulting 
aqueous solution was first washed with ether and aqueous phase was acidified using 
citric acid solution (1 M).  Then ether (3×15 ml) was used to extract the aqueous 
solution again.  The combined organic phases were dried over sodium sulfate, and the 
solvent was removed under reduced pressure to yield a white solid 92.5 mg (92.6%).  
The yielded product appeared as a single spot on TLC and single compound in proton 
NMR. So it required no further purification and was used for the next step 
immediately to avoid decomposition. 1H NMR (400 MHz, CD3CN) δ 0.21 (s, 6H), 
0.99 (s, 9H), 4.48 (s, 2H), 4.59 (s, 2H), 6.34 (d, J=2.4, 1H), 6.50 (dd, J=2.4, 8.5, 1H), 
7.23 (d, J=8.7, 1H). m/z (M+H+-H2O): 295.15, calculated (M+H+-H2O):312.14; 
melting point: 115-116 oC 
2-(3-tert-Butyldimethylsilyloxy-4-(acetoxymethyl)phenoxy)acetic Acid (20). This 
procedure was adapted from literature using a modified procedure for purification s.63  
To a solution of compound 23 (0.070 g, 0.22 mmol) in CH2Cl2 (5 ml), triethylamine 
(0.10 ml, 0.66 mmol) and DMAP (0.008 g, 0.07 mmol) were added. The mixture was 
stirred under room temperature for 2 hours after acetic anhydride (0.04 ml, 0.4 mmol) 
was added to the solution,.  The mixture was then diluted with water (15 ml), and 
extracted with CH2Cl2 (3×10 ml).  The organic phases were combined and dried over 
sodium sulfate and concentrated under reduced pressure.  The crude product was 
purified with silica gel chromatography with hexanes and ethyl acetate (1: 1) to afford 




0.97 (s, 9H), 2.04 (s, 3H), 4.62 (s, 2H), 5.02 (s, 2H), 6.42 (d, J=2.4, 1H), 6.46 (dd, 
J=2.6, 8.5, 1H), 7.21 (d, overlapped with solvent peak); 13C NMR (125 MHz, CDCl3) 
δ -4.0, 18.4, 21.2, 25.8, 62.3, 65.6, 106.4, 106.5, 120.7, 131.9, 155.7, 158.7, 171.4, 
173.1. m/z (M+H+-AcOH): 295.16, calculated (M+H+-AcOH):295.14; melting point: 
98-99 oC  
N-Succinimidyl-2-(3-tert-butyldimethylsilyloxy-4-(acetoxymethyl)phenoxy)-
acetate (QMP2)57. N-hydroxysuccinimide (0.017 g, 0.15 mmol) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, 29 mg, 0.15 mmol) were added to a DMF 
(2 ml) solution of 20 (0.040 mg, 0.11 mmol).  The mixture was then stirred for 20 
hours under room temperature, diluted with brine and extracted with ether (3×15 ml). 
The organic phases were combined and dried over sodium sulfate and concentrated 
under reduced pressure.  The resulting residue was purified by silica gel 
chromatography with hexanes and ethyl acetate (1: 1) to yield the desired activated 
ester of compound 3 as a colorless oil (22 mg, 48%).  1H NMR (400 MHz, CDCl3) δ 
0.23 (s, 6H), 0.97 (s, 9H), 2.02 (s, 3H), 2.83 (s, 4H), 4.90 (s, 2H), 5.00 (s, 2H), 6.43 
(d, J=2.4, 1H), 6.48 (dd, J=2.4, 8.6, 1H) 7.22 (d, overlapped with solvent peak); 13C 
NMR (125 MHz, CDCl3)  δ -4.3, 18.1, 20.9, 25.5, 25.5, 61.8, 63.3, 106.2, 106.5, 
120.9, 131.6, 155.4, 158.3, 164.4, 168.4, 170.9; m/z (M+H+-AcOH): 393.10, 







Chapter 3: DNA-QM self-adduct formation and its DNA 
single strand alkylation is accelerated by using an electron-
rich quinone methide precursor (QMP2) 
3.1 Introduction 
A quinone methide precursor can be delivered to a specific sequence for 
alkylation through a target promoted alkylation process discussed in the first chapter. 
The desired conjugates were prepared by coupling an activated ester form of a 
quinone methide precursor to a site directing ligand. The site directing ligand can be 
single strand DNA or peptide nucleic acid (PNA)64 that can specifically bind to the 
target sequence. After the ligand-QMP conjugate was treated with fluoride to 
generate the quinone methide intermediate, the QM quickly reacted with the nearby 
nucleophiles, such as the bases within the single strand DNA to produce the DNA-
QM self-adduct (Figure 3.1). Previous study demonstrated that the QM regenerates 
spontaneously from its reversible adduct to react with other bases.31 The use of a 
DNA-QM self-adduct for alkylation may find more applications than the DNA-QMP 
conjugate because QM can be generated from the reversible self-adduct without the 
need for an additional chemical signal (like fluoride). This avoids potential side 
effects caused by a triggering compound when applying this process in a biological 
system. In this chapter, both the conventional QMP1 and an electron rich QMP2 were 
coupled to the chosen single strand DNA. DNA-QM self-adduct formation and the 
subsequent single strand DNA alkylation process were tested to study the effect of 




monitored on HPLC (High Performance Liquid Chromatography) since the loss of 
the TBDMS group from the DNA-QMP conjugate greatly increases the polarity of 
the complex allowing it to be eluted sooner on reverse phase HPLC compared to the 
conjugate. According to previous study,31 the DNA-QMP1 conjugate completely 
converted to the corresponding self-adduct in 24 hours. The cross-linking product 
formed by alkylation of the ssDNA using DNA linked QM could be detected with a 
denaturing gel. The maximal alkylation yield of a complementary single strand 
required a 7 days incubation using the DNA-QM1 self-adduct. By using the electron 
rich QMP2, we expect that the formation of the self-adduct will be much faster and 
the maximal alkylation yield will be achieved in a shorter time compared with QMP1. 
This increased reaction rate should make the alkylation process effective in a 
biological system.  
Figure 3.1 Generation of a DNA-QMP conjugate and its DNA-QM self-adduct. 
3.2 Results and Discussion 
3.2.1 Preparation of the DNA-QMP conjugates and DNA-QM self-adducts 
Both the DNA-QMP1 and the DNA-QMP2 conjugates were prepared 
following the same procedure by incubating the quinone methide precursor 




figure 3.2).31 After a 24 hours incubation at room temperature, the conjugates were 
purified by reverse phase HPLC. Both OD1-QMP1 and OD1-QMP2 have very 
similar retention times (around 24 min) on reverse phase HPLC using the same 
elution gradient due to their similar polarity (Figure 3.2 and appendix Figure 17, Page 
105). The corresponding conjugates were collected and characterized by MALDI 
(Table 3.1). After confirming the formation of the conjugates by MALDI, the DNA-
QM self-adducts were generated by incubating the corresponding conjugates with 
potassium fluoride. These products were also purified by HPLC. The retention time 
of the self-adducts were around 14 min (Figure 3.2c). This change in retention time 
resulted from the loss of the very non-polar TBDMS group from the quinone methide 
precursor.31 The collected products were characterized and confirmed MALDI (Table 
3.1 and appendix Figure 15, 16, Page 104). 
Product Calculated Mass Observed Mass 
OD1-QMP1 conjugate 5562.5 5561.8 
OD1-QM1 self-adduct 5388.7 5389.2 
OD1-QMP2 conjugate 5564.5 5564.9 
OD1-QM2 self-adduct 5392.7 5390.8 





OD1 sequence: 5’ NH2~~~TTTCTCTTTTTTCTTCT 
 
Figure 3.2 OD1 sequence and RP-HPLC chromatography of (a) the pure 
oligonucleotide (OD1); (b) OD1-QMP2 conjugate; (c) OD1-QM2 self-adduct. 
Samples were eluted with a linear gradient of 10-55% acetonitrile in aqueous 
triethylammonium acetate (50 mM, pH 5.0) at 1 ml/min over 30 min. 
 
3.2.2 DNA-QM self-adduct formation was promoted by the electron rich QMP2 
As showed above, the DNA-QMP conjugates and DNA-QM self-adducts have 
very distinct retention time when eluting through HPLC. Therefore, HPLC can be 
used to monitor self-adduct formation over time and quantify the product yield with 
the corresponding peak area. After treating the conjugates with fluoride, the TBDMS 
protecting group is removed and the acetate derivative intermediate is generated 
(Figure 3.3). Then quinone methide intermediate is generated upon the left of the 




the acetate derivative can be observed to accumulate on HPLC.31 QM will react with 
a proximal nucleophilic base in the DNA sequence. As a result, a DNA-QM self-
adduct is produced (Figure 3.3). 
  
 Figure 3.3 Illustration of self-adduct formation using QMP1 as the model. The noted 
complex/intermediates are able to be detected on the HPLC.  
 
 
The purified DNA-QMP conjugates were deprotected by addition of KF. The 
mixture was incubated at room temperature and separated by HPLC over different 
incubation time. According to the chromatography, both conjugates showed up 
around 24 min at the beginning of the reaction (0 min) (Figure 3.4a, b). After KF was 
added, the area of conjugate signal was decreased and new product corresponding to 
the acetate derivative (Figure 3.4a) and self-adduct (Figure 3.4a, b) appeared around 
14 min. The acetate derivative was consistent with previous observation.31 The self-
adduct was confirmed by MALDI during preparation discussed above. Finally, all the 
conjugates were converted to the self-adduct since it is the only signal in the 







Figure 3.4 (a) HPLC chromatograph of OD1-QMP1+KF in 0, 40 minutes and 24 
hours; (b) HPLC spectrum of OD1-QMP2+KF in 0, 10, 20 minutes. Both conjugates 
samples were prepared with the same concentration (6.6 µM) and incubated at room 
temperature. Equal amount of the reaction solution was injected to the HPLC at the 
indicated time. Samples were eluted with a linear gradient of 10-55% acetonitrile in 







Only around 20% OD1-QM1 self-adduct was formed after a 20 min 
incubation (Figure 3.4b) while OD1-QMP2 was completely consumed within that 
period of time and formed the OD1-QM2 self-adduct (Figure 3.4a). The OD1-QM1 
generation yield over time was consistent with the previous results where the acetate 
derivative was clearly observed on the HPLC.31 However, no acetate derivative peak 
was ever observed during OD1-QMP2 incubation. This observation agreed with our 
expectation that the generation of QM from QMP2 would be very fast and it might be 
hard to trap the acetate intermediate. These results suggested that generation of QM 
was promoted with the electron donating group in the molecule. The reaction half life 
was around 60 min with QMP1 but less than 5 min with QMP2 (Figure 3.5). This 
acceleration also suggested that regeneration of QM from the reversible self-adduct 
would also be faster for DNA-QM2 compared with DNA-QM1.  
 
Figure 3.5 Product yield of OD1-QM1 self-adduct (black) and OD1-QM2 self-adduct 
(red) generation over time. The data in the plot with error were the average of two 
experimental results. Data without error showed in the plot was one time result. The 




3.2.3 Single strand alkylation of DNA by DNA-QM self-adducts was accelerated 
by increased electron density of the QMP2 
Quinone methides can alkylate a target single strand DNA sequence using a 
complementary single stranded DNA as the site-directing agent (Figure 3.6). In order 
to investigate the effect of the electron donating group on QMP alkylation, OD1-QM 
self-adduct generated from correspond conjugate was incubated with single strand 
OD2 (Figure 3.7).  OD2 is complementary to OD1 sequence and has three more bases 
at the 3’ end. The overhang was added to provide the non-base pairing nucleophiles 
for reaction to QM. Both OD1-QM1 and OD1-QM2 self-adducts were generated in 
situ and incubated with 32P radiolabeled OD2 at room temperature for up to 6 days 
(Figure 3.8). 
 










Figure 3.8 Alkylation of single stranded DNA by DNA-QM1 (a) and DNA-QM2 (b). 
OD1-QM self-adducts were generated in situ by adding KF (100 mM) to the purified 
conjugates (6.6 µM). 32P radiolabeled OD2 was added to the sample after the 
conjugate incubated with KF for 24 hours. The samples were incubated under room 
temperature in MES buffer (20 mM, pH 7) for different periods of time. The final 
concentration of self-adduct was 3.3 µM and OD2 was 3 µM. The samples were then 
analyzed by 20% polyacrymide denaturing gel. Alkylation yield was quantified based 
on the radioactivity of the product bands over the whole sample. 
 
Maximal alkylation yield (20%) of OD2 was reached using the OD1-QM2 
self-adduct within 2 days. However, it took at least 4 days for the OD1-QM1 self-




confirmed our earlier prediction that the use of the electron rich quinone methide 
precursor could accelerate DNA alkylation. However, in the previous report, single 
strand alkylation yield can reach 20% using the self-adduct formed by QMP1.31 My 
self-adduct provided a lower average yield of alkylation. This difference probably 
came from the different sequence QM1 forms self-adduct with. Previously, a mixed 
base sequence was used. In my experiment, OD1 consists of pyrimidines and only the 
cytosine in the sequence would form alkylation adduct with the QM. This decreased 
the efficiency of self-adduct formation and thus limited its subsequent alkylation of 
the single strand DNA. 
 
Figure 3.9 Alkylation yield of OD2 over time. The alkylation yield in the plot is the 




In order to investigate the effect of increased electron density on QM 




coupled to a DNA sequence OD1 to generate a self-adduct and alkylate single strand 
targets. The OD1-QMP1 conjugate which lacked the electron donating group was 
also used as a comparison. Twenty-four hours were necessary to completely convert 
OD1-QMP1 conjugate to the self-adduct but only 20 minutes were needed for OD1-
QMP2 to complete the same process. The single strand alkylation process was also 
accelerated by using OD1-QM2 self-adduct. The maximal yield was achieved within 
the time (2 days) that OD1-QM1 needed (4 days). In conclusion, the electron 
donating group of QMP2 enhanced the alkylation ability of the QM by accelerating 
its QM generation process. This improvement on QM alkylation may be useful when 
applying to the biological system. The alkylation agents can form the cross-linking 
products in a short time before possible degradation happens by nuclease present in 
the system. Quick generation of QM might also help increase the reaction yield as 
discussed in the following chapter.  
3.4 Material and Methods 
Materials 
All the reagents and materials used were obtained from the same source as stated in 
chapter 2. Aqueous buffer solutions were prepared with distilled, deionized water 
with a resistivity of 18.0 MΩ. T4 polynucleotide kinase (PNK) was obtained from 
New England Biolabs (Ipswich, MA). [γ-32P]-ATP was purchased from Perkin-Elmer 
(Waltham, MA). 
General HPLC method 
Oligonucleotides, their conjugates and self-adducts were all purified by reverse-phase 




1 ml/min) of 10-55% acetonitrile in aqueous triethylammonium acetate (50 mM, pH 
5.0) as controlled by a Jasco PU-2080 plus system (Jasco, Easton, MD). Samples 
were manually collected during elution from the HPLC and dialyzed against water to 
remove the salt. The purified product was analyzed by MALDI-TOF in the mass 
spectrometry facility of the Chemistry and Biochemistry Department. 
Preparation of DNA-QMP conjugates: The conjugates were formed by combining 
the quinone methide activated succimidyl ester (1 mg) in CH3CN/DMF (2:1, 300 µL) 
with the 5’aminohexyloligonucleotide (OD1, 15 nmol) in 3-(N-morpholino)-
propanesulfonate buffer (MOPS, 250 mM, pH 7.5, 300 µL) and incubating the 
mixture for 24 hours at room temperature.  The above mixture was then purified by 
HPLC using the gradient above. Pure conjugate was collected in around 55% yield 
(8.5 nmol). The collected portion was dialyzed against water, lyophilized and store at 
-20 oC for future use. 
Formation of the self-adducts from the conjugates: Self-adducts were formed by 
desilylating the TBDMS group of DNA-QMP conjugates (6.6 µm) with KF (0.1 M) 
in 4-morpholineethanesulfonate buffer (MES, 20 mM, pH 7.0) and incubated at room 
temperature  for 24 hours. The formation of self-adduct was monitored by HPLC.  
The mixture was incubated for 24 hours to allow the self-adduct to form and it could 
be used directly for alkylation study without further purification. 
 
Target promoted alkylation and gel electrophoresis 
Target oligonucleotides were 32P-labeled at their 5’ terminus with 5’-[γ-32P]-ATP 




Tris-HCl, 10 mM MgCl2, 5 mM dithiothreitol) and T4 polynucleotide kinase (New 
England Biolabs) using standard protocols. Self-adduct were generated in situ as 
mentioned above. 5’-[32P] target oligonucleotides solution (6 µL, 6 µm) was added to 
self-adduct solution (6 µL, 6 µm in MES: 20 mM, pH 7.0) generated equivalently.  
The mixture remained at room temperature for up to 7 days before analyzed by 
denaturing gel.  After incubation, the samples were added to a loading buffer (0.05% 
bromophenol blue and 0.05% xylene cyanol FF in formamide, 1:1, V/V) and then 
analyzed by denaturing gel electrophoresis (20% acrylamide/7 M urea).  The gel was 
exposed to a phosphorimager plate over night then scanned using a Molecular 
Dynamics Storm Phosphorimager (Sunnyvale, CA).  Products were quantified using 
ImageQuant 5.2 software. The product yield was calculated using the radioactivity of 
the alkylation material divided by the overall radioactivity of the sample. This result 
indicated the percent of the radiolabeled strand that was cross-linked by the alkylating 
agent. The above experiments were repeated and the final yield was determined by 






Chapter 4: Target duplex DNA sequences by DNA-QM 
species through triple helix formation 
4.1 Introduction 
Double stranded DNA in the cell contains all of the genetic information 
necessary for life’s processes. The primary nucleic acid sequence defines the genetic 
code and its secondary structure also has great effect on gene expression and 
regulation. Duplex DNA is considered an important target for developing therapeutic 
treatment because of its leading role in controlling cell activity. 
Triple-helical DNA is one type of multi-stranded DNA structure that can 
affect regular cellular functions. It can be formed with a third strand (triplex forming 
oligonucleotide, TFO) binding to the major groove of the duplex sequence. A poly-
pyrimidine/ poly-purine sequence is required for this binding.65 The triplex binding is 
specific and stable through Hoogsteen hydrogen bonding. Modifications of the base 
and backbone of the TFO can further improve its binding affinity. For example, in the 
parallel pyrimidine triplex motif, substitution of cytosine with a 5-methylcytosine or 
N6-methyl-8-oxo-2-deoxyadenosine has been used to reduce the pH dependence of 
triplex formation (Figure 4.1).66,67  Since regular cytosine in the TFO needs to be 
protonated around pH 5 to form hydrogen bonding with guanine, this modification 
allows the triplex formed and stabilized at neutral pH which makes it applicable in the 
biological system. Although the pKas of cytosine and methylcytosine are almost the 
same (4.4±0.2), the 5-methylcytosine as may stabilize triple helix through enhanced 




modified oligonucleotide were used to induce mutations in the cell68 and also 
increased the binding affinity of the third strand to the duplex in vitro compared to the 
regular ribose backbone.69 Triplex formed by a 2’-OMe modified third strand require 
less distortion of the TFO with the binding duplex.70  
 
Figure 4.1 Hydrogen bonding patterns for triplex formation with modified bases (a) 
5-methylcytosine and (b) N6-methyl-8-oxo-2'-deoxyadenosine in the pyrimidine 
motif.  
 
Small molecules can be attached to the TFO for delivery to a desired site to 
manipulate gene expressing.71 One example of this is coupling a gene cleaver to the 
TFO for sequence specific cleavage. Common gene cleavers include Fe-EDTA72 and 
biologically active enzymes like micrococcal nuclease.73 These conjugates cleaved 
the DNA at the specific site and produce DNA fragments for gel electrophoreic 
analysis (Figure 4.2a).72 Oligonucleotide clamping is another example of gene 
targeting through triple helix formation. A single oligonucleotide was designed with 
two parts of a sequence connected by a linker (Figure 4.2b). Of the two DNA 
sequence parts, one part binds first to the homopurine74 or homopyrimidine75 target 




formed duplex to generate a triplex structure. This “clamp” structure inhibited chain 
elongation during DNA replication of a single stranded template in vitro by DNA 
polymerase.76 Psoralen is another molecule that has been coupled to the TFO. 
Psoralen intercalates into the major groove of double strand DNA while the TFO 
binds to the major groove. The intercalation helps stabilize the triplex structure. 
Psoralen can also be activated through UV radiation to form DNA cross-links (Figure 
4.2c). Psoralen reacts at AT base pairs and cross-links thymine. This light activated 
molecule allows control of the timing for damage and reduces non-specific damage to 













Figure 4.2 Examples of applications based on triple helical structure. (a) Strand 
scission by TFO coupled with a cleaving agent. (b) Oligonucleotide clamping on a 
single stranded nucleic acid. (c) Site specific alkylation by psoralen linked TFO. 
Diagram was adapted from literature.71  
 
Seidman’s group developed a gene targeting method using psoralen-linked 
TFO.44,77 The target sequence selected was in the fourth intron next to exon 5 of the 
CHO Hprt gene (Scheme 4.1). This sequence contains a 17-base polypurine: 
polypyrimidine sequence with a 5’-TA base at the end which was used as a cross-
linking site of psoralen. Mutagenesis by this TFO in the living cell was observed. 




aminoethyl substitution showed the best activity.78 Around 20~30% of the cross-
linking adducts formed by the TFO-psoralen conjugate induced mutation (>5% 
mutation frequency) indicating an effect target binding and mutagenesis by TFOs in 
living cell.  
Inspired by this application of a DNA cross-linker in gene targeting, our 
quinone methide reagents should be tested in this system leading to mutations. 
Instead of using the photo-active molecule psoralen, quinone methide could be 
generated from DNA-QM self-adducts and react with the bases without any chemical 
or light initiation. The use of QM could avoid possible side reactions that might be 
induced by light.  
 
 
Scheme 4.1 Hprt gene target sequence. This sequence contains a recognition site for 
restriction enzyme XbaI (TCTAG) which was used for digestion purpose to analyze 
the cross-linking products.44 
 
In this chapter, conditions to alkylate the target duplex DNA in vitro were 
optimized. Both DNA-QMP conjugates and DNA-QM self-adducts were prepared for 
alkylation study. The TFO sequence was also modified to promote the alkylation by 
enhancing triplex binding. Various target sequences were also tested to find the 
optimal sequence for QM alkylation. The electron rich quinone methide precursor 




should be accelerated with QMP2 and its enhanced reactivity should also help 
increase the alkylation efficiency. 
 4.2 Results and Discussion 
4.2.1 Preparation of the DNA-QMP conjugate and DNA-QM self-adduct 
The DNA-QMP conjugate and DNA-QM self-adduct species used for 
alkylation in this chapter were prepared following the procedure provided in Chapter 
3. The DNA-QM self-adducts were generated by adding KF to the corresponding 
conjugates. They were either generated in situ for alkylation or purified through 
HPLC prior to incubate with the duplex as indicated in the specific experiment.  
4.2.2 ssDNA alkylation by TFO-QMP1 conjugate 
The target duplex sequence chosen for the alkylation was adapted from the 
CHO Hprt gene introduced above. The TFO sequence (OD1) is listed below (Scheme 
4.2). It is a 17-base long poly-pyrimidine sequence that binds to the poly-purine part 
of the target duplex to form a triplex structure. In order to ensure that only the QM 
formed cross-linking with target sequence through triplex formation, OD1-QMP1 
conjugate was first incubated with selected single strand DNA (OD2 or OD3, Scheme 
4.2) to check for the alkylation products. 
Alkylation of a single strand DNA is expected when a target strand anneals to 
the delivery strand to form duplex. Incubation of the OD1-QMP1 conjugate with 
OD2, which was complementary to OD1, was used as a positive control to confirm its 
alkylation ability. OD3 represents polypurine sequence of the target duplex (red box 





when it formed double strand DNA. So the sequence of OD3 was complementary to 
OD1 through Hoogsteen base pairs in a parallel direction. We expected no cross-
linking between two strands because they should not form duplex. OD1-QMP1 was 
incubated with radiolabeled OD3 in MES 20 mM, pH 7 at room temperature and KF 
was added to initiate reaction. Alkylation products of OD2 by the OD1-QMP1 
conjugate were detected by gel electrophoresis and the maximal yield around 68% 
was achieved within 24 hours (Figure 4.3a). Less than 5% alkylation was observed 
for OD3 using OD1-QMP1. This result agreed with our expectation that the OD1-
QMP1 conjugate could not alkylate a target that could not form a duplex. Therefore, 
any cross-linking products observed with OD1 and this type of parallel 
complementary purine strand could only result from triplex formation (Figure 4.3b).  
 
Scheme 4.2 TFO sequence OD1 and the single strand DNA sequences (OD2 and 





Figure 4.3 Alkylation of single strand DNA OD2 (a) and OD3 (b) by the OD1-QMP1 
conjugate. OD1-QMP1 (3.3 µM) and radiolabeled single strand DNA (3.0 µM) were 
incubated in MES (20 mM, pH 7). KF (100 mM) was added to initiate the reaction. 
The samples incubated at room temperature for 0-4 days. Then the samples were 





4.2.3 Alkylation of the target duplex DNA by OD1-QMP1 conjugates 
A target duplex DNA was prepared by annealing complementary single 
strands OD4 and OD5. The dsDNA sequence was adapted from the target Hprt gene. 
It contained the 17-base long homopurine/pyrimidine section for TFO binding 
(Scheme 4.3). Duplex OD4/OD5 was designed with 5 additional base pairs at both 
termini of the homopurine/pyrimidine region to stabilize the double helical structure. 
These bases also provided nucleophiles from beyond the triplex binding region so that 
QM could alkylate bases without destabilizing the triplex structure. OD1-QMP1 
conjugate was incubated with OD4/OD5 and reaction was initiated with fluoride. 
Samples were incubated in MES (20 mM, pH 5) with MgCl2 (10 mM). Divalent 
cation like Mg2+ stabilizes the triplex by reducing the electrostatic repulsive forces 
between the negatively charged phosphate backbones of the three strands.65  The 
cross-linking product was not observed consistently on the gel (Figure 4.4). Although 
we did see a high molecular weight product in less than a 10% yield (3 days and 4 
days sample in the gel of figure 4.4), the DNA tended to migrate irregularly on the gel 
and lacked a distinct single band (1 day and 2 days sample in same gel). This 
irregular migration was observed repeatedly. 
 





Figure 4.4 Alkylation of target duplex OD4/OD5 by OD1-QMP1. [32P]-OD4/OD5 
(0.1 µM) was pre-annealed in MES buffer. OD1-QMP1 (10.0 µM) was added to the 
duplex (0.05 µM) and KF (100 mM) was used to activate the QM. The sample was 
incubated in MES buffer (20 mM, pH 5) with NaCl (150 mM) and MgCl2 (10 mM) 
under ambient conditions for 0~4 days. Samples were analyzed by 20% 
polyacrylamide denaturing gel without any further treatment. Ctrl: single strand [32P]-
OD4 in the incubation buffer. 
 
 
Various methods were tested to solve the inconsistent mobility issue of the 
DNA.  Ultimately, the fluoride and magnesium in the sample solution were found 
responsible for disturbed proper migration of the cross-linked material on the gel 
(Figure 4.5, lane 2). Ethylenediaminetetraacetic acid (EDTA) was added to the 
solution to help solve this problem. EDTA could chelate Mg2+ to prevent possible 
precipitation caused by Mg2+ and F-.  With the addition of EDTA, the cross-linking 
products reappeared on the gel (Figure 4.5, lane 3). However, use of EDTA did not 
help with the triplex samples and the still no distinct alkylation band was observed. 






Figure 4.5 Salt effects on alkylation and migration of DNA products through a 
denaturing gel. OD1-QMP1 (3.3 µM), [32P]-OD2 (3.0 µM) and KF (100 mM) were 
incubated in MES (20 mM, pH 6) with different salt concentrations. Lane 1: No salt 
added; Lane 2: NaCl (150 mM) and MgCl2 (10 mM); Lane 3: NaCl (150 mM) and 
MgCl2 (10 mM) with EDTA (10 mM); Lane 4: NaCl (150 mM). 
 
Finally, samples had to be desalted using P6 columns to remove the ions in 
the solution before analysis by the denaturing gel. Single distinct high molecular 
weight signals representing the cross-linking products were observed on the gel after 
samples were desalted (Figure 4.6). OD1-QMP1 conjugates was incubated with [32P]-
OD4/OD5 in MES (20 mM, pH 5) with 150 mM  NaCl, 2.5 mM  MgCl2 and 100 mM 
KF at room temperature. Lower concentration of MgCl2 was used here than used in 
the previous sample (10 µM) to minimize its effect on DNA migration on the gel. The 
above buffer concentration is regarded as the standard condition for duplex alkylation 






Figure 4.6 Alkylation of double strand DNA by OD1-QMP1. Double strands [32P]-
OD4/OD5 (samples without specification) and OD4/ [32P]-OD5 (specified in the 
figure) were pre-annealed in MES buffer (20 mM, pH 5) with NaCl (150 mM) and 
MgCl2 (2.5 mM). OD1-QMP1 (10.0 µM) was added to the duplex (0.05 µM) and KF 
(100 mM) was used to initiate the reaction. The samples were incubated under 
ambient conditions for 1~4 days. Samples were desalted using P6 columns before 
analyzed by the 20% polyacrylamide denaturing gel.  
 
 
Only around 10% alkylation product was formed with the polypurine binding 
strand (OD4) after a 4-day incubation by observing the cross-linking products with 
radiolabeled purine strand. The cross-linking yield with the polypyrimidine strand 
(OD5) was even lower (6%). These yields are too low for alkylation to make an effect 
in a biological system. Efforts discussed below were made to improve the alkylation 
yield. 
4.2.4 Sequence dependent alkylation by OD1-QMP1 conjugate 
One way to increase the alkylation yield of DNA is to provide the QM with 
nucleophiles that are preferred to react with. Previous study of QM alkylation through 
triplex formation showed that QM preferred to react with adjacent guanine to the 




duplexes were designed with guanines adjacent to the binding site of TFO next to 
QM. The new targets were modified from OD4/OD5 by deleting the AT base pair 
adjacent to the binding region and next to QMP to place a guanine at the adjacent site 
(Scheme 4.4). OD1 can still bind to the duplex and would be adjacent to guanine to 
promote QM alkylation. The guanine was placed in the pyrimidine strand (OD7) in 
duplex OD6/OD7 and in the purine strand (OD8) in duplex OD8/OD9. The OD1-
QMP1 conjugate was incubated with OD6/OD7 and OD8/OD9 separately and the 
denaturing gels are shown below (Figure 4.7). Either polypyrimidine or polypurine 
strands were radiolabeled to prepare totally 4 duplex samples. All of them were 
incubated with the conjugates and then analyzed by gel electrophoresis. The results 
indicated that the alkylation yield increased when there was an adjacent guanine to 
QM in the target sequence. When the polypurine strand was radiolabeled, the yield 
reached around 20% after a 5 day incubation with guanine adjacent to the binding 
region (OD8) compared to around 10% yield when no guanine was present (Figure 
4.7). The results agreed with our prediction that adjacent guanine could improve the 
alkylation yield by promoting alkylation reaction with QM. When the polypyrimidine 
strand was radiolabeled, cross-linking products with the pyrimidine strand had a 
lower yield than that of the purine strand. This result also indicated that QM preferred 
to react with adjacent bases. Target duplex OD8/OD9 provided with the best 
alkylation efficiency of all three duplex DNAs we studied so far. Thus, this sequence 





Scheme 4.4 New duplex sequences with adjacent guanine (highlighted in red). 
 
 
Figure 4.7 Sequence dependent alkylation by OD1-QMP1. OD1-QMP1 (10.0 µM) 
was incubated with the indicated duplex sequence (0.05 µM) under standard 
condition for up to 5 days. Samples were desalted before loading on a denaturing gel. 
Control samples were either lacking cross-linking agent or KF. Cross-linking 
products with polypurine strand are showed in gel (a); cross-linking products with 





4.2.5 Modified TFO was used to enhance triplex binding 
To further increase the alkylation efficiency, a modified TFO (TFO1) was 
conjugated to the QMP to enhance its binding. TFO1 contained the exact same 
sequence as OD1 except that the cytosines in the strand were ethylated on their 5 
position of the pyrimidine ring. This modification allows triplex formation at neutral 
condition. It also enhanced the binding by increasing the Tm of the third strand.66 The 
TFO1-QMP1 conjugate was incubated the OD8/OD9 (Scheme 4.5). The alkylation 
yield reached 27% after 7 days incubation (Figure 4.8). The yield was higher 
compared to alkylation by OD1-QMP1 conjugate. As expected, the duplex alkylation 
was improved by incorporating modified bases in the TFO sequence. 
 
Scheme 4.5 TFO1 sequence and target duplex sequences.  
 
 
Figure 4.8 Modified TFO sequences (TFO1) and alkylation of OD8/OD9 with TFO1 
linked QMP1. The cytosines showed in blue color in the sequence represent 5-methyl 
cytosine. Purified TFO1-QMP1 (5.0 µM) was incubated with pre-annealed [32P]-
OD8/OD9 (0.05 µM) and KF (100 mM) using standard condition for up to 7 days. 
Samples were desalted before analyzed by the denaturing gel electrophoresis.  
4.2.6 DNA-QM1 self-adduct showed limited ability to alkylate the target duplex 
In addition to use of the DNA-QMP1 conjugate to alkylate target duplex, 




necessary to trigger QM reaction from the self-adduct. QM can be regenerated 
spontaneously from the reversible self-adducts to promote alkylation of  DNA.31 This 
property provides a promising future for in vivo application since KF used to activate 
QMP is toxic to cells. OD1-QM1 self-adduct used for triplex alkylation was purified 
through HPLC before incubating with the target duplex. As a result, the fluoride ion 
was removed and no extra desalting step was necessary before gel analysis. The 
TFO1-QM1 self-adduct was incubated with duplex OD8/OD9 alternatively at pH 5 
and pH 7 to check for its pH effect. However, no obvious alkylation was observed 
under either condition (Figure 4.9).  
 
Figure 4.9 Alkylation of duplex DNA by the TFO1-QM1 self-adduct. TFO1-QM1 
self-adduct was prepared by incubating the TFO1-QMP1 conjugate with KF for 24 
hours and the products was purified by HPLC. Pre-annealed double strand [32P]-
OD8/OD9 (0.05 µM) and purified TFO1-QM1 (5.00 µM) were mixed in MES buffer 
(20 mM) with NaCl (150 mM) and MgCl2 (2.5 mM) at pH 5 and pH 7. Samples were 
incubated under ambient condition for up to 5 days and then analyzed by denaturing 
gel without any further treatment. The control sample contained only OD8/OD9 in 




The experiments discussed in section 4.2.4 showed that the OD1-QMP1 
conjugate can successfully alkylate the target duplex with decent yield. This 
confirmed the formation of the triple helix between the chosen TFO and target 
duplex. The reasons that the alkylation yield of the TFO1-QM1 self-adduct was so 
low might be the limited reactivity of QM released from the self-adduct. Or, the 
DNA-QM self-adduct might not be thermodynamically favored to bind and react with 
the duplex based on the folded structure. TFO needs to be correctly folded for QM to 
react with the base in the TFO sequence. If QM reacted with cytosine close to the 3’ 
terminus, the resulting DNA-QM self-adduct may not be able bind tight enough to the 
duplex sequence because of limited bases positioned correctly for hydrogen bonding 
(Figure 4.10). In order to solve this issue, another modified TFO with a 15 base poly-
pyrimidine sequence and an unpaired adenine at the 5’ end was designed (TFO2, 
Scheme 4.6). TFO2 contains the sequence that can still bind to the duplex target. The 
modification on 5’ end should be helpful since QM can only react with the cytosine in 
the pyrimidine strand.80 The added adenine can provide a strong nucleophilic site to 
react with QM. The reversible self-adducts formed with this site regenerate the QM 
readily.45  Addition of adenine increased the chance of generating self-adduct with a 
less folded sequence since QM can react with adenine and cytosine that are close to 
itself (5’ terminus). Besides, the unpaired adenine can also act as a linker between 
DNA and QMP which may extend the distance for QM to reach for possible 
nucleophiles. The TFO2-QM1 self-adduct was incubated with pre-annealed 
OD4/OD5 for up to 4 days. Duplex OD4/OD5 was used to provide an adjacent 




result indicated that third strand binding of the self-adduct to the duplex was not the 
problem for the low alkylation yield. 
 
Figure 4.10 Possible folded structure of a TFO-QM1 self-adduct. Bases that are 
folded during self-adduct formation could not bind to dsDNA to form triplex. 
 
Scheme 4.6 TFO2 sequences and its target duplex. 
 
 
Figure 4.11 Alkylation of duplex DNA by TFO2-QM1 self-adducts. TFO2 sequence 
is listed above and contains the unpaired adenine. The TFO2-QM1 (10.0 µM) self-
adduct was generated in situ and [32P]-OD4/OD5 (0.05 µM) was added. Samples 
were incubated in MES (20 mM) with NaCl (150 mM) and MgCl2 (2.5 mM) at pH 5. 
A P6 column was used to desalt samples before analysis by the denaturing gel 
electrophoresis. Lane 1 was a control with only [32P]-OD4/OD5 in the buffer for 4 
days. The sample of lane 2 contained 100 equiv. of the self-adduct (5.00 µM). 




Modifications on the target sequences were also tested to promote the 
alkylation of the QM. An unpaired guanine adjacent to the QM was added into the 




Thus, the energy barrier for the alkylation was lowered and the reaction kinetics were 
increased. As a result, DNA alkylation product was likely to be produced. Based on 
this idea, new duplex targets were designed from the original sequence (Scheme 4.7). 
They all contain the same 17-base TFO binding region but differ in the position of 
unpaired guanines. Duplex OD10/OD11 and OD12/OD13 have three extra bases 
(GCG) which are not paired in the sequence. Duplex OD14/OD15 and OD16/OD17 
contain one unpaired G. Both OD1-QMP1 conjugate and OD1-QM1 self-adducts 
were incubated at room temperature for 6 days and around 20% alkylation was 
detected for samples treated with OD1-QMP1. However, alkylation by the OD1-QM1 
self-adduct produced less than 5% alkylation (Figure 4.11). One possible reason for 
this result is that the extra bases added in the target sequence cannot be reached by the 
QM since the bulge part was likely to be positioned outside the major groove of the 
duplex structure.  In order to provide an unpaired guanine within the DNA double 
helix structure, another target duplex (OD16/OD18) with an abasic site was prepared. 
The guanine (highlighted in red) in OD16 that is adjacent to the binding region next 
for QMP has no base to form hydrogen bonding in the opposite strand. As a result, 
the guanine is placed within the double helical structure and no hydrogen bonding 
needs to be broken if react with QM. However, alkylation yield of this duplex with an 
abasic site was still low (<2%) after a 6 day incubation. (The gel is included in the 
appendix Figure 19, Page 106). The low yield obtained with the newly designed 
targets suggested that the modifications we introduced to the duplex did not improve 
the alkylation yield very much. Other ways were needed to help with the alkylation 





Scheme 4.7 Modified duplex sequences for QM alkylation. Adjacent guanine bases 
were showed in red. The purple uracil indicates the abasic site. 
 
 
Figure 4.12 Alkylation of the modified sequences: [32P]-OD10/OD11 (Lane 1 and 5); 
[32P]-OD12/OD13 (Lane 2 and 6); [32P]-OD14/OD15 (Lane 3 and 7); [32P]-
OD16/OD17 (Lane 4 and 8). Both the OD1-QMP1 conjugate and the OD1-QM1 self-
adduct were incubated with the target duplex for 6 days under standard condition and 
then analyzed by denaturing gel after desalting. Only purine strand was radiolabeled 





4.2.7 DNA-QM2 self-adducts showed good ability for duplex DNA alkylation 
Alkylation of double strand DNA by the DNA-QM1 self-adduct was observed 
but with very limited yield compared to the alkylation by the conjugates. Triplex 
formation with the target sequence was confirmed with alkylation products produced 
by OD1-QMP1 conjugates. Available nucleophiles were provided to promote 
alkylation. However, neither enhanced binding of the third strand nor preferred 
nucleophiles for QM improved the alkylation yield. This suggested that the DNA-QM 
self-adduct itself might be the major issue responsible for the low alkylation 
efficiency. The QM1 released from the self-adduct might have limited reactivity with 
the bases. Therefore, a new QM that could be generated and regenerated more readily 
than QM1 might help with the alkylation. As introduced in Chapter 2 and 3, an 
electron rich quinone methide precursor (QMP2) was synthesized and coupled to 
DNA to promote the kinetics of the single strand alkylation. QM2 was regenerated 
from OD1-QM2 self-adduct faster than OD1-QM1 species (Figure 3.5). With this fast 
regeneration and increased reactivity, OD1-QM2 should react with the duplex targets 
with higher efficiency than OD1-QM1. 
 The OD1-QM2 self-adduct was prepared and purified under standard 
condition and then added to OD8/OD9. Samples were incubated using standard 
conditions at room temperature for 1-7 days. OD1-QM1 self-adduct samples were 
also included as a control. When the OD1-QM2 self-adduct was used, a maximal 
target alkylation of 20% was produced in 3 days (Figure 4.13). In contrast, cross-
linking product was barely observed on the gel using the OD1-QM1 self-adduct with 




QM2 self-adduct over the OD1-QM1 self-adduct. This improvement in alkylation 
might be due to the fact that quinone methide intermediate was released more readily 
to react with nucleophilic sites on DNA.  Time dependent alkylation study showed 
that the maximal alkylation was reached within 4 days of incubation (Figure 4.14).  
 
 
Figure 4.13 Alkylation of target duplex by OD1-QM2 and OD1-QM1 self-adducts. 
The self-adducts were prepared from the corresponding conjugates and added to the 
[32P]-OD8/OD9 (0.5 µM) in 100 fold excess (5 .0 µM). Samples were incubated 
under standard condition. Control sample was included that only [32P]-OD8/OD9 was 






Figure 4.14 Alkylation over time plot with OD1-QM2 and [32P]-OD8/OD9. The data 
in the plot represent the average value of two experiments and error of the data 
represents the range of the yield. 
 
4.2.8 Concentration dependent alkylation by OD1-QM2 self-adduct 
 In order to learn the minimal concentration of OD1-QM2 necessary for 
alkylation, a concentration dependent experiment was performed. Previous study of 
alkylation through triplex formation showed that a 200 fold excess of the DNA linked 
alkylating agent was necessary to support a maximal yield of 30% within 3 days.79  
Thus, a range of the OD1-QM2 self-adduct concentration was incubated with the 
double strand [32P]-OD8/OD9 for 5 days at room temperature. The results (Figure 
4.15) indicated that as low as a 10 fold excess of the self-adduct was enough for QM 
to obtain a maximal yield of target alkylation of 12%. All future experiments 
contained a 50 fold excess of the OD1-QM2 self-adduct to ensure the optimized 
condition for alkylation. However, the amount of the alkylation reagents used is still 









Figure 4.15 Dosage dependent alkylation results. Samples were prepared following 
the standard procedure. (a) Different amount of OD1-QM2 was incubated with [32P]-
OD8/OD9 (0.05 µM) for 5 days and then analyzed by denaturing gel. (b) Alkylation 
yield over self-adduct plot. Data in the plot with error were averaged value by 2 
experimental results. Data without error were from one time experiment. The error 







4.2.9 Sequence and temperature effect on alkylation of target duplex by OD1-
QM2 self-adduct 
The OD1-QM2 self-adduct was incubated with different target dsDNAs to 
measure the efficiency of alkylation. The experimental results confirmed that the QM 
preferred to react with an adjacent guanine. The OD1-QM2 self-adduct was incubated 
with pre-annealed duplex [32P]-OD4/OD5, [32P]-OD6/OD7, OD6/[32P]-OD7, [32P]-
OD8/OD9 separately (Figure 4.16). Cross-linking products were observed with strand 
of OD7 and OD8 in which a guanine is next to the QM. When incubating the self-
adduct with duplex OD4/OD5, no cross-linking products were evident on the gel for 
either strand since there was no adjacent guanine in the strand. Alkylation presented 
by this gel was lower than normal (around 15% after 4 days incubation) because the 
self-adducts were only incubated with target duplex for 2 days. Therefore, the 












Figure 4.16 Alkylation of different duplex sequences by OD1-QM2. Samples were 
incubated under standard condition for 2 days. Lane 1: OD8/O9 control; Lane 2: 




The effect of temperature on alkylation of the dsDNA through a triple helix 
structure was also studied to check the QM2 activity at body temperature. Triple 
helical structures are usually stabilize with decrease temperature.81 However, QM 
reacts more efficiently at room temperature than at lower temperature.80  The 
temperature effect on single strand alkylation also confirmed this (Figure 4.17). 
Alkylation was observed when incubating the OD1-QMP1 conjugate with 
complementary ssDNA OD2 at room temperature (Lane 1, 3 and 5). However, the 




incubating in the same buffer condition at 4 oC (Lane 2 and 4). This also indicated a 
slow generation of QM from its precursor at a lower temperature. So the triplex 
samples were all incubated at room temperature for best results. However, when the 
electron rich OD1-QMP2 conjugate aqueous solution was examined after stored at -
18 oC for 3 months, a peak corresponding to its self-adduct was showed on MALDI 
spectrum (Figure 4.18). This gradual formation of self-adduct suggested that QMP2 
could be activated to generate QM even without addition of fluoride due to the highly 
reactivity. 
 
Figure 4.17 Alkylation of OD2 by OD1-QMP1 at different temperature. OD1-QMP1 
(6.6 µM) was added to [32P]-OD2 (6 µM) in MES (20 mM). KF (100 mM) was 
applied to initiate the reaction. Samples were incubated for 4 days under: Lane 1: pH 
6; rt; Lane 2: pH 6; 4 oC; Lane 3: pH 7; 4 oC; Lane 4: pH 7; rt with NaCl (150 mM) 





Figure 4.18 MALDI data of OD1-QMP2 conjugated after stored at -18 oC in water 
for 3 months. The major peak was the conjugate (calculated: 5564.5; observed: 
5564.5); but the self-adduct also appeared (calculated: 5392.7; observed: 5390.6) 
 
Inspired by this reactivity, we proposed that an increase of temperature could 
enhance the ability of QM2 to alkylate its target. Both the OD1-QMP2 conjugate and 
the OD1-QM2 self-adduct were incubated with OD8/OD9 in 4 oC, 21 oC (room 
temperature) and 37 oC.  The samples were incubated for up to 4 days and then 
loaded on the denaturing gel without any further treatment. According to the gel 
results (Figure 4.19), the alkylation using the OD1-QM2 self-adduct provided the best 
yield when samples were incubated under 37 oC (Lane 3).  No alkylation was 
apparent for the sample incubated at 4 oC (Lane 4) which was likely to indicate a very 
slow reaction. For the samples using the OD1-QMP2 conjugate, alkylation was 
observed even without adding KF. The highest yield was also achieved with samples 
incubated under 37 oC. Alkylation yield of 26% was achieved after 4 days incubation 




observed for QM alkylation through triplex system. Since no fluoride was necessary 
to trigger the alkyation reaction of the QMP, the DNA-QMP conjugate might be 
directly applied in a biological system. Further studies to check the reproducibility of 
the temperature effect are necessary. 
 
Figure 4.19 Temperature effect on duplex alkylation. OD1-QM2 (50 equiv.) was 
incubated with [32P]-OD8/OD9 (Lane 1-4) in MES buffer (20 mM, pH 5) with NaCl 
(150 mM) and MgCl2 (2.5 mM). OD1-QMP2 (50 equiv.) was incubated with [32P]-
OD8/OD9 (Lane 5~9) with the same buffer with or without KF (100 mM). Lane 1: (-
)KF, rt., 3 days; Lane 2:  (-)KF, 4 oC, 1 day, then rt. 2 days; Lane 3: (-)KF, 37 oC, 3 
days; Lane 4: (-)KF, 4 oC, 2 days; Lane 5: (-)KF, rt., 3 days; Lane 6: (+)KF, rt., 3 
days; Lane 7: (-)KF, rt., 4 oC 1 day, then rt. 2 days; Lane 8: (-)KF, 37 oC 2 days; Lane 




Both QMP1 and QMP2 were conjugated to a TFO strand and successfully 
delivered to the selected duplex DNA through triplex formation. All samples were 
incubated in acidic buffer at room temperature.  In order to display a distinct 
alkylation products band on the denaturing gel, samples had to be desalted to remove 
Mg2+ and F- in the solution, which interrupted the DNA migration on the gel. The 
formation of alkylation products using the DNA-QMP1 conjugate was observed when  




of the duplex, which binds to the TFO, provided the best yield. The maximal yield 
was 21% achieved after a 5-day incubation. The alkylation yield could also be 
increased by enhancing the third strand binding with a modified TFO1 containing 
methyl cytosines to replace regular cytosine in the sequence. The maximal yield was 
increased to 27% after 7 days incubation. 
Although duplex alkylation was observed with the DNA-QMP1 conjugate, its 
self-adduct showed almost no alkylation with the target dsDNA. A modified TFO 
sequence with an unpaired adenine to form a reversible adduct with QM failed to 
improve alkylation yield. Target sequences were also modified to provide with 
adjacent guanine without hydrogen bonding for a lower the energy barrier of the 
alkylation reaction. The alkylation yield was not improved with this modification 
either.  
An electron rich QMP2 was coupled to the TFO and its self-adduct was 
generated for alkylation. The OD1-QM2 self-adduct successfully alkylated the target 
duplex in a relative high yield (20%) and the maximal yield was achieved in 3 days. 
Concentration dependent study showed that as low as a 10 fold excess of alkylating 
agent was necessary to achieve the maximal alkylation yield. This amount of 
alkylation agents used was ¼ of what was reported previously in triplex alkylation.79 
Preliminary study on the temperature effect suggested that electron rich QMP2 could 
be activated at 37 oC without fluoride. This enhanced alkylation efficiency provided 
by the electron rich QM2 self-adduct will allow for its future application in living cell 




4.4 Materials and Methods 
Materials: All single stranded DNA were purchased from IDT (Coralville, IA). 
Aqueous solutions were prepared with distilled, deionized water with a resistivity of 
18.0 MΩ. T4 polynucleotide kinase (PNK) was obtained from New England Biolabs 
(Ipswich, MA). [γ-32P]-ATP was purchased from Perkin-Elmer (Waltham, MA). 
Micro bio-spin columns with bio-gel P-6 was purchased from Bio-Rad (Hercules, 
CA). Single strand DNA with an abasic site was obtained from Yang Liu of the 
Rokita group. 
Preparation of double strand DNA: Duplex DNA was prepared by annealing two 
complementary single strands. The indicated strand (100 nM) was radioabled at its 5’ 
terminus using standard protocols. Both radiolabed strand and its complementary 
strand (200 nM) were mixed in 40 mM 4-morpholineethanesulfonate (MES, pH 5) 
with 5 mM MgCl2, 300 mM NaCl or the specified salt concentration. The mixture 
was heated to 90 oC for 3 minutes and allowed to cool to room temperature over more 
than 3 hours. The solution was stored in the -20 oC freezer for future use. 
 
Alkylation of target duplex by TFO-QMP conjugate/TFO-QM self-adduct: The 
TFO linked alkylation agent was added to the duplex solution.  For samples using the 
TFO-QMP conjugate, the reaction was initiated by addition of aqueous KF (100 
mM). Final concentrations were 0.5 µM duplex DNA, 2.5 µM alkylation agent 
(DNA-QMP conjugate or self-adduct), 2.5 mM MgCl2, 150 mM NaCl, 20 mM MES 
(pH 5). Duplex was radiolabed at the specified strand. Alkylation agent concentration 




indicated period of time. Electrophoresis loading solution (0.05% xylene cyanol and 
0.05% bromphenol blue in formamide) was added in equal volume which also 
quenched the reaction when the incubation time was finished. Products were analyzed 
by denaturing gel electrophoresis (20% acrylamide/7 M urea) with standard TBE 
buffer (Tris-Borate-EDTA) and quantified by phosphoimagery using imagequant 
software. Alkylation yields were calculated based on the radioactivity of the product 
and overall radioactivity of the sample. Samples requiring desalting used the Micro 











Chapter 5:  Conclusion 
As a small molecule alkylating agent, quinone methide attracted our attention 
not only because of it could alkylate bases in the DNA to form alkylation products, 
but also because of its ability to form reversible covalent bonds with the strong 
nucleophiles of the bases. As a result, the QM can be regenerated from reversible 
adducts spontaneously for alkylation without the need of any triggering chemicals or 
energy source. In the target promoted alkylation process, QM was delivered to the 
target DNA sequence by a DNA-QM self-adduct and alkylation products were 
formed.31 However, the reaction was slow. Seven days were necessary for the DNA-
QM self-adduct to reach a maximal alkylation yield of 20% when alkylating a 
complementary single strand DNA. This was too slow for application in a biological 
system since DNA repair processes may fix the alkylation before it could affect the 
DNA activity. Therefore, it was necessary to accelerate the reaction by creating a 
more reactive quinone methide. This dissertation presents the program of designing 
and synthsizing an electron rich quinone methide precursor and measuring how fast 
the reaction is accelerated by this increased electron density. Investigation of the 
optimized condition for duplex alkylation by DNA-QMP and DNA-QM through 
triplex structure formation is also discussed. 
Substitution effects of an QM described by others indicated that the presence 
of an electron rich donating group in the quinone mehtide precursor would facilitate 
the generation of QM from QMP and its regeneration from the adducts.35 Attempts of 
synthesizing a QMP2 were made to produce siyl protected quinone methide precursor 




previous synthesis scheme of QMP1 was not applicable to this new precursor because 
of the modification. The reactions used to construct QMP1 including formation of 
benzylic hydroxyl group and generation of benzylic acetate group from protected 
hydroxyl group were not working on similar substrates with an electron donating 
group present. Therefore, synthesis of the QMP2 was finally achieved through a 
novel six-step procedure. An aldehyde starting material was used to avoid 
constructing the benzylic hydroxyl group under basic condition with heat, which is 
notorious for its low yield (<20%) and difficult separation due to multiple products 
formation.45 In comparison, the reduction reaction yielded single product with high 
yield (>80%) and the aldehyde group did not need to be protected during synthesis 
since it was not evolved in reactions of other steps. The overall yield for previous 4-
step synthesis plan (Figure 2.2) is around 3.5% while the overall yield for QMP2 
(Figure 2.7) is around 4.2% after 6 steps. The new synthesis route is more efficient 
and the synthetic study of the electron rich QMP2 provides important experiences and 
references for future synthesis design. 
The electron rich QMP2 generates QM much faster to form its self-adduct 
than the conventional QMP1 as we predicted. Target alkylation of single strand DNA 
is also accelerated. Alkylation using QMP2 required less than half amount of time (3 
days) for maximal yield compared to 7 days required for QMP1.   This improvement 
on alkylation speed of DNA linked QM should make the alkylation process more 
effective for future in vivo study. 
Alkylation of a duplex DNA using DNA-QMP conjugates and DNA-QM self-




observed using DNA-QMP1 conjugates incubating with target duplex. Adjacent 
guanine in the target sequence is very important for alkylation which is consistent 
with previous results.82 However, the DNA-QM1 self-adduct showed limited ability 
in duplex alkylation due to its slow kinetics of QM regeneration from its self-adduct. 
Thus, DNA-QM2 self-adduct was tested for alkylation. Alkylation products were 
observed and maximal yield was reached within 4 days. The best yield around 20% 
was achieved by incubation of the self-adduct with target duplex containing an 
adjacent guanine. This is the first time that alkylation of a dsDNA is observed with a 
DNA-QM self-adduct. Compared to target alkylation with a single strand DNA, the 
third strand binding is weaker than dsDNA but the alkylation provides a similar yield 
in a shorter time using the electron rich QMP2. The alkylation yield could be further 
improved with increased temperature (at 37 oC) and the DNA-QMP2 conjugate 
showed ability to alkylate the duplex at 37 oC without KF. These results demonstrate 
the advantages of using QMP2 to alkylate duplex DNA and prepare the DNA-QM2 
self-adduct for future applications in cells. 
Above all, the electron rich QMP2 solved a major issue of DNA alkylation by 
DNA-QM self-adducts. It speeded up the single strand alkylation process. It also 
increased the alkylation yield of target dsDNA. These improvements made the self-
adduct species ready for in cell application. Compared to psoralen, another commonly 
used DNA cross-linking agent, the DNA-QM has several advantages. No chemical or 
light is necessary to initiate the alkylation since QM can be released from the self-
adduct spontaneously. In contrast, UV-radiation is required for psoralen reaction 




Psoralen required AT base pair for cross-linking and this may limit the target 
sequence selection. The adjacent guanine required for optimized alkylation of QM is 
convenient to construct in the polypurine binding strand. However, psorlen provides 
the maximal yield in shorter time (around 15 min) than QM which is also the reason 
why it was widely used in the cell.83  For the future direction of this research work, 
TFO linked electron rich quinone methide self-adducts could be applied to the Hprt 
gene and its alkylation can be analyzed by the gene targeting assay developed by 
Seidman’s group which is used to measure the mutation caused by alkylation.44  
Detailed study is necessary for temperature effect on duplex alkylation using 
DNA-QMP2 conjugates. If the conjugate was confirmed to be reactive at body 
temperature without the use of KF, it could be applied directly to the cells. This 
provides an alternative method for QMP activation. The use of the DNA-QMP2 
conjugate can further increase the alkylation yield from the use of self-adduct since 
all the QM generated from precursor could have the chance to alkylate the target 
DNA. In contrast, only the reversible adducts of the DNA-QM self-adducts would 
regenerate the QM to alkylate the target sequence. Successful activation of QMP at 










NMR spectra of the compounds in QMP2 synthesis (Figure 2.7) 
 
                                      







                                          





                     





   




                     
                         
 
 




                          
 




        
 




                        




                         
 
 
                           Figure 9 1H NMR of compound 20 in CD3CN at 400 MHz. 




                      
 




                     
 





                          
 




                      
 
 
                               Figure 13 1H NMR of QMP2 in CDCl3 at 400 MHz. 




                      
 
                                  















(a)                 (b)     
Figure 15 MALDI of (a) OD1-QMP1 conjugate: calculated mass was 5562.5, 
found by MALDI was 5561.8; (b) OD1-QM1 self-adduct: calculated mass was 
5388.7, found by MALDI was 5389.2. 
        (a)             (b)  
Figure 16 MALDI of (a) OD1-QMP2 conjugate: calculated mass was 5564.5, 
found by MALDI was 5564.9; (b) OD1-QM2 self-adduct: calculated mass was 
5392.7, found by MALDI was 5390.8. The mass peak 5408.3 corresponds to 





Figure 17 HPLC separation of OD1-QMP1 conjugate (24.6 min peak) and OD1-
QM1 self-adduct (13.2 min peak). Samples were eluted with a linear gradient of 10-
55% acetonitrile in aqueous triethylammonium acetate (50 mM, pH 5.0) at 1 ml/min 




Figure 18 Alkylation of target duplex OD4/OD5 by OD1-QMP1. [32P]-OD4/OD5 
(0.1 µM) was pre-annealed in MES buffer. OD1-QMP1 (10.0 µM) was added to the 
duplex (0.05 µM) and KF (100 mM) was used to activate the QM. The sample was 
incubated in MES buffer (20 mM, pH 5) with NaCl (150 mM) and MgCl2 (10 mM) 
under ambient conditions for 0~4 days. EDTA was added to the samples before 
analysis by 20% polyacrylamide denaturing gel. Ctrl: single strand [32P]-OD4 in the 






Figure 19 Alkylation of duplex with an upaired adjacent guanine by OD1-QM1 self-
adduct. Puified OD1-QM1 (10.0 µM) was incubated with [32P]-OD16/OD17 (0.05 
µM) and OD16/[32P]-OD18 (0.05 µM) separately. Samples were incubated under 
standard conditions for 2, 3 and 6 days. Samples were analyzed by denaturing gel 
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